Raras
Buscar doenças, sintomas, genes...
Retinite pigmentosa
ORPHA:791CID-10 · H35.5CID-11 · 9B70OMIM 268000DOENÇA RARA

Retinose pigmentar (RP) é uma doença genética que afeta a retina, causando a perda gradual das células responsáveis pela visão e das células de suporte da retina, e que geralmente resulta em cegueira depois de muitas décadas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Retinose pigmentar (RP) é uma doença genética que afeta a retina, causando a perda gradual das células responsáveis pela visão e das células de suporte da retina, e que geralmente resulta em cegueira depois de muitas décadas.

Pesquisas ativas
40 ensaios
313 total registrados no ClinicalTrials.gov
Publicações científicas
11.520 artigos
Último publicado: 2026 Apr 16
Medicamentos
7 registrados
VALPROIC ACID, CARBIDOPA ANHYDROUS, METHOTREXATE

Tem tratamento?

7 medicamentos registrados
Ver detalhes, fases e interações →
VALPROIC ACIDCARBIDOPA ANHYDROUSMETHOTREXATELEVODOPACARBIDOPAHYDROXYCHLOROQUINEBRIMONIDINE

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
30.0
Europe
Início
Adolescent
+ adult, childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
72 sintomas
🧠
Neurológico
5 sintomas
📏
Crescimento
5 sintomas
🦴
Ossos e articulações
4 sintomas
🫘
Rins
3 sintomas
🫁
Pulmão
3 sintomas

+ 41 sintomas em outras categorias

Características mais comuns

100%prev.
Distrofia de cones e bastonetes
Frequência: 20/20
90%prev.
Atrofia óptica
Muito frequente (99-80%)
90%prev.
Deficiência visual
Muito frequente (99-80%)
90%prev.
Eletroretinograma anormal
Muito frequente (99-80%)
90%prev.
Cegueira
Muito frequente (99-80%)
90%prev.
Cegueira noturna progressiva
Muito frequente (99-80%)
144sintomas
Muito frequente (14)
Frequente (15)
Ocasional (3)
Sem dados (112)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 144 características clínicas mais associadas, ordenadas por frequência.

Distrofia de cones e bastonetesRod-cone dystrophy
Frequência: 20/20100%
Atrofia ópticaOptic atrophy
Muito frequente (99-80%)90%
Deficiência visualVisual impairment
Muito frequente (99-80%)90%
Eletroretinograma anormalAbnormal electroretinogram
Muito frequente (99-80%)90%
CegueiraBlindness
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico11.520PubMed
Últimos 10 anos200publicações
Pico2026146 papers
Linha do tempo
2026Hoje · 2026🧪 1978Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

92 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, Mitochondrial inheritance, X-linked recessive.

AHI1JouberinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in vesicle trafficking and required for ciliogenesis, formation of primary non-motile cilium, and recruitment of RAB8A to the basal body of primary cilium. Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Involved in neuronal differentiation. As a positive modulator of classical Wnt signaling, may play a crucial role in cili

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCell junction, adherens junctionCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 3

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 3 shows minimal extra central nervous system involvement and appears not to be associated with renal dysfunction.

OUTRAS DOENÇAS (4)
Joubert syndrome 3Joubert syndromeretinitis pigmentosaJoubert syndrome with ocular defect
HGNC:21575UniProt:Q8N157
AIPL1Aryl-hydrocarbon-interacting protein-like 1MENDELIANTolerante
FUNÇÃO

May be important in protein trafficking and/or protein folding and stabilization

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 4

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

OUTRAS DOENÇAS (4)
Leber congenital amaurosis 4AIPL1-related retinopathycone-rod dystrophyLeber congenital amaurosis
HGNC:359UniProt:Q9NZN9
HK1Hexokinase-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the phosphorylation of various hexoses, such as D-glucose, D-glucosamine, D-fructose, D-mannose and 2-deoxy-D-glucose, to hexose 6-phosphate (D-glucose 6-phosphate, D-glucosamine 6-phosphate, D-fructose 6-phosphate, D-mannose 6-phosphate and 2-deoxy-D-glucose 6-phosphate, respectively) (PubMed:1637300, PubMed:25316723, PubMed:27374331). Does not phosphorylate N-acetyl-D-glucosamine (PubMed:27374331). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to

LOCALIZAÇÃO

Mitochondrion outer membraneCytoplasm, cytosol

VIAS BIOLÓGICAS (2)
GlycolysisSynthesis of GDP-mannose
MECANISMO DE DOENÇA

Anemia, congenital, non-spherocytic hemolytic, 5

An autosomal recessive disorder characterized by hemolytic anemia as the predominant clinical feature, and decreased red cell hexokinase activity.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
153.8 TPM
Cerebelo
139.0 TPM
Esôfago - Mucosa
123.5 TPM
Skin Sun Exposed Lower leg
114.2 TPM
Aorta
113.3 TPM
OUTRAS DOENÇAS (4)
neurodevelopmental disorder with visual defects and brain anomaliesretinitis pigmentosa 79non-spherocytic hemolytic anemia due to hexokinase deficiencyCharcot-Marie-Tooth disease type 4G
HGNC:4922UniProt:P19367
HKDC1Hexokinase HKDC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the phosphorylation of hexose to hexose 6-phosphate, although at very low level compared to other hexokinases (PubMed:30517626). Has low glucose phosphorylating activity compared to other hexokinases (PubMed:30517626). Involved in glucose homeostasis and hepatic lipid accumulation. Required to maintain whole-body glucose homeostasis during pregnancy; however additional evidences are required to confirm this role (By similarity)

LOCALIZAÇÃO

CytoplasmMitochondrion membranePhotoreceptor inner segment

VIAS BIOLÓGICAS (1)
Glycolysis
MECANISMO DE DOENÇA

Retinitis pigmentosa 92

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP92 is an autosomal recessive, mild form with onset of night blindness and vision loss in the third to sixth decades of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
28.3 TPM
Rim - Medula
10.6 TPM
Rim - Córtex
10.1 TPM
Nervo tibial
9.8 TPM
Tireoide
5.6 TPM
OUTRAS DOENÇAS (1)
retinitis pigmentosa 92
HGNC:HGNC:23302UniProt:Q2TB90
RAX2Retina and anterior neural fold homeobox protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in modulating the expression of photoreceptor specific genes. Binds to the Ret-1 and Bat-1 element within the rhodopsin promoter

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Macular degeneration, age-related, 6

A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pituitária
1.9 TPM
Fallopian Tube
0.9 TPM
Útero
0.7 TPM
Cervix Endocervix
0.1 TPM
Testículo
0.1 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 95cone-rod dystrophy 11age related macular degeneration 6cone-rod dystrophy
HGNC:18286UniProt:Q96IS3
CRXCone-rod homeobox proteinDisease-causing germline mutation(s) inModerado
FUNÇÃO

Transcription factor that binds and transactivates the sequence 5'-TAATC[CA]-3' which is found upstream of several photoreceptor-specific genes, including the opsin genes. Acts synergistically with other transcription factors, such as NRL, RORB and RAX, to regulate photoreceptor cell-specific gene transcription. Essential for the maintenance of mammalian photoreceptors

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 7

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Fígado
0.1 TPM
Ovário
0.0 TPM
Cerebelo
0.0 TPM
Cérebro - Hemisfério cerebelar
0.0 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 7cone-rod dystrophy 2retinitis pigmentosacone-rod dystrophy
HGNC:2383UniProt:O43186
KLHL7Kelch-like protein 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex. The BCR(KLHL7) complex acts by mediating ubiquitination and subsequent degradation of substrate proteins. Probably mediates 'Lys-48'-linked ubiquitination

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Perching syndrome

An autosomal recessive multisystem disorder characterized by global developmental delay, dysmorphic facial features, feeding and respiratory difficulties with poor overall growth, axial hypotonia, and joint contractures. The features are variable, even within families, and may also include retinitis pigmentosa, cardiac or genitourinary anomalies, and abnormal sweating.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
28.9 TPM
Cérebro - Hemisfério cerebelar
19.6 TPM
Coração - Ventrículo esquerdo
16.2 TPM
Cerebelo
14.7 TPM
Fibroblastos
14.5 TPM
OUTRAS DOENÇAS (6)
PERCHING syndromeretinitis pigmentosa 42KLHL7-related cold-induced sweating-like syndromeKLHL7-related Bohring-Opitz-like syndrome
HGNC:15646UniProt:Q8IXQ5
PRPF31U4/U6 small nuclear ribonucleoprotein Prp31Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11867543, PubMed:20118938, PubMed:28781166). Required for the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:11867543)

LOCALIZAÇÃO

NucleusNucleus speckleNucleus, Cajal body

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 11

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
81.5 TPM
Útero
81.1 TPM
Fibroblastos
77.6 TPM
Linfócitos
76.5 TPM
Cervix Ectocervix
76.4 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 11retinitis pigmentosa
HGNC:15446UniProt:Q8WWY3
ARL3ADP-ribosylation factor-like protein 3Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP) (PubMed:16525022, PubMed:18588884). Required for normal cytokinesis and cilia signaling (PubMed:22085962). Requires assistance from GTPase-activating proteins (GAPs) like RP2 and PDE6D, in order to cycle between inactive GDP-bound and active GTP-bound forms. Required for targeting

LOCALIZAÇÃO

Golgi apparatus membraneCytoplasm, cytoskeleton, spindleNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasmCell projection, cilium

VIAS BIOLÓGICAS (1)
Trafficking of myristoylated proteins to the cilium
MECANISMO DE DOENÇA

Joubert syndrome 35

A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS35 inheritance is autosomal recessive.

OUTRAS DOENÇAS (4)
retinitis pigmentosa 83Joubert syndrome 35Joubert syndromeretinitis pigmentosa
HGNC:694UniProt:P36405
TOPORSE3 ubiquitin-protein ligase ToporsDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions as an E3 ubiquitin-protein ligase and as an E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA damage-induced cell death through IKBKE sumoylation

LOCALIZAÇÃO

NucleusNucleus, PML body

VIAS BIOLÓGICAS (3)
SUMOylation of immune response proteinsSUMOylation of transcription cofactorsSUMOylation of SUMOylation proteins
MECANISMO DE DOENÇA

Retinitis pigmentosa 31

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
31.6 TPM
Ovário
23.5 TPM
Fibroblastos
21.4 TPM
Fallopian Tube
18.9 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 31retinitis pigmentosaorofaciodigital syndrome type 6
HGNC:21653UniProt:Q9NS56
TULP1Tubby-related protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal development of photoreceptor synapses. Required for normal photoreceptor function and for long-term survival of photoreceptor cells. Interacts with cytoskeleton proteins and may play a role in protein transport in photoreceptor cells (By similarity). Binds lipids, especially phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4

LOCALIZAÇÃO

CytoplasmCell membraneSecretedSynapse

MECANISMO DE DOENÇA

Retinitis pigmentosa 14

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Próstata
1.5 TPM
Útero
1.4 TPM
Fallopian Tube
1.2 TPM
Cervix Endocervix
1.1 TPM
Skin Sun Exposed Lower leg
1.0 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 15retinitis pigmentosa 14Leber congenital amaurosisretinitis pigmentosa
HGNC:12423UniProt:O00294
RP1Microtubule-associated protein RP/EB family member 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Adapter protein that is involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. Therefore, ensures mitotic progression and genome stability (PubMed:27030108). Acts as a central regulator of microtubule reorganization in apico-basal epithelial differentiation (By similarity). Plays a role during oocyte meiosis by regulating microtubule dynamics (By similarity). Participates in neurite growth by interacting with plexin B3/PLXNB3 a

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

MECANISMO DE DOENÇA

Skin creases, congenital symmetric circumferential, 2

An autosomal dominant disease characterized by multiple, symmetric, circumferential rings of folded skin, affecting primarily the limbs. Affected individuals also exhibit intellectual disability, cleft palate, and dysmorphic features.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.9 TPM
Pulmão
0.8 TPM
Rim - Medula
0.3 TPM
Fallopian Tube
0.3 TPM
Estômago
0.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 1retinitis pigmentosa
HGNC:10263UniProt:Q15555
IDH3AIsocitrate dehydrogenase [NAD] subunit alpha, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (2)
Citric acid cycle (TCA cycle)Mitochondrial protein degradation
MECANISMO DE DOENÇA

Retinitis pigmentosa 90

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP90 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
41.9 TPM
Coração - Átrio
30.6 TPM
Artéria tibial
26.4 TPM
Cérebro - Hemisfério cerebelar
25.3 TPM
Músculo esquelético
25.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 90retinitis pigmentosa
HGNC:5384UniProt:P50213
PDE6GRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones

LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 57

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
8.5 TPM
Linfócitos
8.0 TPM
Sangue
2.8 TPM
Testículo
2.5 TPM
Rim - Medula
2.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 57retinitis pigmentosa
HGNC:8789UniProt:P18545
SPATA7Spermatogenesis-associated protein 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the maintenance of both rod and cone photoreceptor cells (By similarity). It is required for recruitment and proper localization of RPGRIP1 to the photoreceptor connecting cilium (CC), as well as photoreceptor-specific localization of proximal CC proteins at the distal CC (By similarity). Maintenance of protein localization at the photoreceptor-specific distal CC is essential for normal microtubule stability and to prevent photoreceptor degeneration (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeletonCell projection, cilium, photoreceptor outer segment

MECANISMO DE DOENÇA

Leber congenital amaurosis 3

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
61.8 TPM
Cérebro - Hemisfério cerebelar
16.1 TPM
Ovário
14.7 TPM
Pituitária
14.6 TPM
Cerebelo
13.8 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 3severe early-childhood-onset retinal dystrophyLeber congenital amaurosisretinitis pigmentosa
HGNC:20423UniProt:Q9P0W8
POMGNT1Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Participates in O-mannosyl glycosylation by catalyzing the addition of N-acetylglucosamine to O-linked mannose on glycoproteins (PubMed:11709191, PubMed:27493216, PubMed:28512129). Catalyzes the synthesis of the GlcNAc(beta1-2)Man(alpha1-)O-Ser/Thr moiety on alpha-dystroglycan and other O-mannosylated proteins, providing the necessary basis for the addition of further carbohydrate moieties (PubMed:11709191, PubMed:27493216). Is specific for alpha linked terminal mannose and does not have MGAT3,

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (3)
DAG1 core M1 glycosylationsDAG1 core M2 glycosylationsMatriglycan biosynthesis on DAG1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3

An autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, cobblestone lissencephaly, and cerebellar and pontine hypoplasia. Patients present severe congenital myopia, congenital glaucoma, pallor of the optic disks, retinal hypoplasia, intellectual disability, hydrocephalus, abnormal electroencephalograms, generalized muscle weakness and myoclonic jerks. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
61.9 TPM
Tireoide
61.2 TPM
Brain Spinal cord cervical c-1
57.1 TPM
Testículo
54.0 TPM
Nervo tibial
52.7 TPM
OUTRAS DOENÇAS (8)
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3retinitis pigmentosa 76autosomal recessive limb-girdle muscular dystrophy type 2O
HGNC:19139UniProt:Q8WZA1
RGRRal-GDS-related proteinDisease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Cytoplasmic vesicle

VIAS BIOLÓGICAS (2)
OpsinsG alpha (i) signalling events
EXPRESSÃO TECIDUAL(Tecido-específico)
Córtex cerebral
5.5 TPM
Brain Anterior cingulate cortex BA24
5.1 TPM
Brain Frontal Cortex BA9
4.5 TPM
Brain Nucleus accumbens basal ganglia
3.1 TPM
Brain Caudate basal ganglia
3.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 44retinitis pigmentosa
HGNC:9990UniProt:Q8IZJ4
ZNF408Zinc finger protein 408Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

May be involved in transcriptional regulation

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 6

An autosomal dominant form of exudative vitreoretinopathy, a form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
17.9 TPM
Útero
17.1 TPM
Skin Not Sun Exposed Suprapubic
15.7 TPM
Bladder
15.6 TPM
Fallopian Tube
15.5 TPM
OUTRAS DOENÇAS (4)
exudative vitreoretinopathy 6retinitis pigmentosa 72exudative vitreoretinopathyretinitis pigmentosa
HGNC:20041UniProt:Q9H9D4
PROM1Prominin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in cell differentiation, proliferation and apoptosis (PubMed:24556617). Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (P

LOCALIZAÇÃO

Apical cell membraneCell projection, microvillus membraneCell projection, cilium, photoreceptor outer segmentEndoplasmic reticulumEndoplasmic reticulum-Golgi intermediate compartment

VIAS BIOLÓGICAS (1)
Developmental Lineage of Pancreatic Ductal Cells
MECANISMO DE DOENÇA

Retinitis pigmentosa 41

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
69.0 TPM
Rim - Medula
33.8 TPM
Cólon transverso
13.8 TPM
Intestino delgado
11.7 TPM
Testículo
8.3 TPM
OUTRAS DOENÇAS (7)
Stargardt disease 4retinitis pigmentosa 41retinal macular dystrophy type 2cone-rod dystrophy 12
HGNC:9454UniProt:O43490
CFAP418Cilia- and flagella-associated protein 418Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in photoreceptor outer segment disk morphogenesis (By similarity)

LOCALIZAÇÃO

CytoplasmPhotoreceptor inner segment

MECANISMO DE DOENÇA

Cone-rod dystrophy 16

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (5)
cone-rod dystrophy 16bardet-biedl syndrome 21cone-rod dystrophyretinitis pigmentosa
HGNC:27232UniProt:Q96NL8
IDH3BIsocitrate dehydrogenase [NAD] subunit beta, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a structural role to facilitate the assembly and ensure the full activity of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperativ

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Citric acid cycle (TCA cycle)
MECANISMO DE DOENÇA

Retinitis pigmentosa 46

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
161.6 TPM
Cerebelo
157.3 TPM
Útero
137.1 TPM
Ovário
130.8 TPM
Cervix Ectocervix
129.5 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 46retinitis pigmentosa
HGNC:5385UniProt:O43837
RPE65Retinoid isomerohydrolaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Critical isomerohydrolase in the retinoid cycle involved in regeneration of 11-cis-retinal, the chromophore of rod and cone opsins. Catalyzes the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol which is further oxidized by 11-cis retinol dehydrogenase to 11-cis-retinal for use as visual chromophore (PubMed:16116091). Essential for the production of 11-cis retinal for both rod and cone photoreceptors (PubMed:17848510). Also capable of catalyzing the isomerizati

LOCALIZAÇÃO

CytoplasmCell membraneMicrosome membrane

VIAS BIOLÓGICAS (1)
The canonical retinoid cycle in rods (twilight vision)
MECANISMO DE DOENÇA

Leber congenital amaurosis 2

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Substância negra
4.6 TPM
Hipotálamo
2.6 TPM
Brain Spinal cord cervical c-1
0.8 TPM
Próstata
0.6 TPM
Hipocampo
0.5 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 20Leber congenital amaurosis 2retinitis pigmentosa 87 with choroidal involvementRPE65-related recessive retinopathy
HGNC:10294UniProt:Q16518
GUCA1BGuanylyl cyclase-activating protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Stimulates two retinal guanylyl cyclases (GCs) GUCY2D and GUCY2F when free calcium ions concentration is low, and inhibits GUCY2D and GUCY2F when free calcium ions concentration is elevated (By similarity). This Ca(2+)-sensitive regulation of GCs is a key event in recovery of the dark state of rod photoreceptors following light exposure (By similarity). May be involved in cone photoreceptor response and recovery of response in bright light (By similarity)

LOCALIZAÇÃO

Cell membranePhotoreceptor inner segmentCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 48

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
8.6 TPM
Cerebelo
7.7 TPM
Nervo tibial
7.0 TPM
Testículo
6.6 TPM
Cervix Ectocervix
6.1 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 48retinitis pigmentosa
HGNC:4679UniProt:Q9UMX6
TMEM216Transmembrane protein 216Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Essential for primary ciliogenesis and embryonic development, facilitating the activation of Hedgehog (Hh) signaling pathway. Disrupts the interaction of GLI2 and GLI3 with the negative regulator SUFU. Inhibiting SUFU's interaction with GLI2 promotes the entry of GLI2 into the nucleus, allowing it to activate Hh target gene expression. Disrupting SUFU's interaction with GLI3 prevents its conversion into the repressor form, leading to increased nuclear GLI3 and enhanced Hh signaling. Required for

LOCALIZAÇÃO

MembraneCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 2

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
31.3 TPM
Pituitária
27.0 TPM
Cervix Endocervix
25.9 TPM
Cervix Ectocervix
24.7 TPM
Testículo
23.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 98Meckel syndrome, type 2Joubert syndrome 2Meckel syndrome
HGNC:25018UniProt:Q9P0N5
SLC7A14Solute carrier family 7 member 14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Imports 4-aminobutanoate (GABA) into lysosomes. May act as a GABA sensor that regulates mTORC2-dependent INS signaling and gluconeogenesis. The transport mechanism and substrate selectivity remain to be elucidated

LOCALIZAÇÃO

Lysosome membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 68

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.6 TPM
Cerebelo
15.0 TPM
Pituitária
14.2 TPM
Hipotálamo
9.8 TPM
Brain Spinal cord cervical c-1
9.2 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 68retinitis pigmentosa
HGNC:29326UniProt:Q8TBB6
CNGB1Cyclic nucleotide-gated channel beta-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of the rod cyclic nucleotide-gated channel. Mediates rod photoresponses at dim light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyperpolar

LOCALIZAÇÃO

Cell membraneCell projection, cilium membrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 45

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 45retinitis pigmentosa
HGNC:2151UniProt:Q14028
RP9Retinitis pigmentosa 9 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Is thought to be a target protein for the PIM1 kinase. May play some roles in B-cell proliferation in association with PIM1 (By similarity)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Retinitis pigmentosa 9

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
29.6 TPM
Cervix Endocervix
24.2 TPM
Cérebro - Hemisfério cerebelar
23.6 TPM
Tireoide
23.3 TPM
Útero
23.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 9retinitis pigmentosa
HGNC:10288UniProt:Q8TA86
PRCDPhotoreceptor disk component PRCDDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in vision

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembraneEndoplasmic reticulumGolgi apparatus

MECANISMO DE DOENÇA

Retinitis pigmentosa 36

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
21.0 TPM
Cérebro - Hemisfério cerebelar
20.5 TPM
Brain Spinal cord cervical c-1
8.0 TPM
Cervix Endocervix
6.6 TPM
Cervix Ectocervix
6.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 36retinitis pigmentosa
HGNC:32528UniProt:Q00LT1
IFT140Intraflagellar transport protein 140 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs) (PubMed:20889716, PubMed:22503633). Plays a pivotal role in proper development and function of ciliated cells through its role in ciliogenesis and/or cilium maintenance (PubMed:22503633). Required for the development and maintenance of the outer segments of rod and cone photoreceptor cells. Plays a role in maintenance and the delivery of opsin to

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 9 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. SRTD9 is characterized by phalangeal cone-shaped epiphyses, chronic renal disease, nearly constant retinal dystrophy, and mild radiographic abnormality of the proximal femur. Occasional features include short stature, cerebellar ataxia, and hepatic fibrosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
59.8 TPM
Testículo
47.9 TPM
Pituitária
34.4 TPM
Ovário
31.1 TPM
Cervix Endocervix
29.6 TPM
OUTRAS DOENÇAS (8)
retinitis pigmentosa 80cranioectodermal dysplasia 5short-rib thoracic dysplasia 9 with or without polydactylyJeune syndrome
HGNC:29077UniProt:Q96RY7
REEP6Receptor expression-enhancing protein 6Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Required for correct function and survival of retinal photoreceptors (PubMed:27889058). Required for retinal development (By similarity). In rod photoreceptors, facilitates stability and/or trafficking of guanylate cyclases and is required to maintain endoplasmic reticulum and mitochondrial homeostasis (By similarity). May play a role in clathrin-coated intracellular vesicle trafficking of proteins from the endoplasmic reticulum to the retinal rod plasma membrane (By similarity)

LOCALIZAÇÃO

Endoplasmic reticulum membraneCytoplasmic vesicle, clathrin-coated vesicle membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 77

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP77 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
670.0 TPM
Fígado
250.5 TPM
Glândula adrenal
115.7 TPM
Intestino delgado
63.1 TPM
Próstata
34.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 77retinitis pigmentosa
HGNC:30078UniProt:Q96HR9
PRPF3U4/U6 small nuclear ribonucleoprotein Prp3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex)

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 18

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
61.9 TPM
Tireoide
59.6 TPM
Nervo tibial
54.5 TPM
Cervix Endocervix
52.6 TPM
Cervix Ectocervix
50.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 18retinitis pigmentosa
HGNC:17348UniProt:O43395
CC2D2ACoiled-coil and C2 domain-containing protein 2ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity)

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 6

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

OUTRAS DOENÇAS (8)
retinitis pigmentosa 93COACH syndrome 2Joubert syndrome 9Meckel syndrome, type 6
HGNC:29253UniProt:Q9P2K1
PRPF6Pre-mRNA-processing factor 6Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:20118938, PubMed:21549338, PubMed:28781166). Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but does not affect estrogen-induced transactivation

LOCALIZAÇÃO

Nucleus, nucleoplasmNucleus speckle

VIAS BIOLÓGICAS (3)
Dengue Virus-Host InteractionsmRNA Splicing - Major PathwaymRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 60

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
173.8 TPM
Cerebelo
153.8 TPM
Linfócitos
119.8 TPM
Ovário
112.4 TPM
Skin Sun Exposed Lower leg
108.4 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 60retinitis pigmentosa
HGNC:15860UniProt:O94906
CRB1Protein crumbs homolog 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in photoreceptor morphogenesis in the retina (By similarity). May maintain cell polarization and adhesion (By similarity)

LOCALIZAÇÃO

Apical cell membraneSecretedCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (6)
pigmented paravenous retinochoroidal atrophyLeber congenital amaurosis 8retinitis pigmentosa 12retinitis pigmentosa
HGNC:2343UniProt:P82279
RHORhodopsinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Photoreceptor required for image-forming vision at low light intensity (PubMed:7846071, PubMed:8107847). Required for photoreceptor cell viability after birth (PubMed:12566452, PubMed:2215617). Light-induced isomerization of the chromophore 11-cis-retinal to all-trans-retinal triggers a conformational change that activates signaling via G-proteins (PubMed:26200343, PubMed:28524165, PubMed:28753425, PubMed:8107847). Subsequent receptor phosphorylation mediates displacement of the bound G-protein

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (4)
OpsinsG alpha (i) signalling eventsThe canonical retinoid cycle in rods (twilight vision)Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 4

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
0.5 TPM
Cerebelo
0.5 TPM
Cérebro - Hemisfério cerebelar
0.5 TPM
Córtex cerebral
0.5 TPM
Testículo
0.2 TPM
OUTRAS DOENÇAS (6)
retinitis pigmentosa 4fundus albipunctatuscongenital stationary night blindness autosomal dominant 1retinitis pigmentosa
HGNC:10012UniProt:P08100
RLBP1Retinaldehyde-binding protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Soluble retinoid carrier essential the proper function of both rod and cone photoreceptors. Participates in the regeneration of active 11-cis-retinol and 11-cis-retinaldehyde, from the inactive 11-trans products of the rhodopsin photocycle and in the de novo synthesis of these retinoids from 11-trans metabolic precursors. The cycling of retinoids between photoreceptor and adjacent pigment epithelium cells is known as the 'visual cycle'

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)The retinoid cycle in cones (daylight vision)Defective visual phototransduction due to RDH5 loss of function
MECANISMO DE DOENÇA

Bothnia retinal dystrophy

A type of retinitis punctata albescens. Affected individuals show night blindness from early childhood with features consistent with retinitis punctata albescens and macular degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Caudate basal ganglia
11.3 TPM
Córtex cerebral
11.2 TPM
Brain Putamen basal ganglia
10.5 TPM
Brain Frontal Cortex BA9
9.5 TPM
Brain Anterior cingulate cortex BA24
7.6 TPM
OUTRAS DOENÇAS (5)
fundus albipunctatusNewfoundland cone-rod dystrophyBothnia retinal dystrophyretinitis pigmentosa
HGNC:10024UniProt:P12271
SAGS-arrestinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO (By similarity). May play a role in preventing light-dependent degeneration of retinal photoreceptor cells (PubMed:9565049)

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 1

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is an autosomal recessive form associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
7.2 TPM
Brain Nucleus accumbens basal ganglia
4.1 TPM
Brain Caudate basal ganglia
1.2 TPM
Brain Putamen basal ganglia
0.7 TPM
Cervix Endocervix
0.4 TPM
OUTRAS DOENÇAS (5)
Oguchi disease-1retinitis pigmentosa 47retinitis pigmentosa 96retinitis pigmentosa
HGNC:10521UniProt:P10523
AGBL5Cytosolic carboxypeptidase-like protein 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Metallocarboxypeptidase that mediates deglutamylation of tubulin and non-tubulin target proteins. Catalyzes the removal of polyglutamate side chains present on the gamma-carboxyl group of glutamate residues within the C-terminal tail of alpha- and beta-tubulin. Cleaves alpha- and gamma-linked polyglutamate tubulin side-chain, as well as the branching point glutamate. Also catalyzes the removal of alpha-linked glutamate residues from the carboxy-terminus of alpha-tubulin. Mediates deglutamylation

LOCALIZAÇÃO

Cytoplasm, cytosolNucleusCytoplasm, cytoskeleton, spindleMidbody

VIAS BIOLÓGICAS (1)
Carboxyterminal post-translational modifications of tubulin
MECANISMO DE DOENÇA

Retinitis pigmentosa 75

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP75 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 75retinitis pigmentosa
HGNC:26147UniProt:Q8NDL9
RPGRX-linked retinitis pigmentosa GTPase regulatorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:20631154). GEF activity towards RAB8A may facilitate ciliary trafficking by modulating ciliary intracellular localization of RAB8A (PubMed:20631154). GEF activity towards RAB37 maintains autophagic homeostasis and retinal function (By similarity). Involved in photoreceptor integrity (By similarity). May control cilia formation by regulating ac

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, flagellum axonemeGolgi apparatusCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, cilium axoneme

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 3

An X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.9 TPM
Nervo tibial
17.6 TPM
Tecido adiposo
15.5 TPM
Fallopian Tube
14.7 TPM
Pulmão
14.3 TPM
OUTRAS DOENÇAS (9)
macular degeneration, X-linked atrophicretinitis pigmentosa 3obsolete primary ciliary dyskinesia-retinitis pigmentosa syndromeX-linked cone-rod dystrophy 1
HGNC:10295UniProt:Q92834
KIAA1549UPF0606 protein KIAA1549Disease-causing germline mutation(s) inRestrito
FUNÇÃO

May play a role in photoreceptor function

LOCALIZAÇÃO

MembraneCell projection, cilium

VIAS BIOLÓGICAS (1)
Signaling by BRAF and RAF1 fusions
MECANISMO DE DOENÇA

Retinitis pigmentosa 86

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP86 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
5.0 TPM
Córtex cerebral
4.9 TPM
Útero
3.9 TPM
Pituitária
3.6 TPM
Glândula salivar
3.5 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 86pilomyxoid astrocytomaretinitis pigmentosa
HGNC:22219UniProt:Q9HCM3
BBS1BBSome complex member BBS1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
OUTRAS DOENÇAS (3)
Bardet-Biedl syndrome 1retinitis pigmentosaBardet-Biedl syndrome
HGNC:966UniProt:Q8NFJ9
LRATLecithin retinol acyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transfers the acyl group from the sn-1 position of phosphatidylcholine to all-trans retinol, producing all-trans retinyl esters (PubMed:9920938). Retinyl esters are storage forms of vitamin A (Probable). LRAT plays a critical role in vision (Probable). It provides the all-trans retinyl ester substrates for the isomerohydrolase which processes the esters into 11-cis-retinol in the retinal pigment epithelium; due to a membrane-associated alcohol dehydrogenase, 11 cis-retinol is oxidized and conver

LOCALIZAÇÃO

Endoplasmic reticulum membraneRough endoplasmic reticulumEndosome, multivesicular bodyCytoplasm, perinuclear region

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)Retinoid metabolism and transport
MECANISMO DE DOENÇA

Leber congenital amaurosis 14

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
3.3 TPM
Brain Spinal cord cervical c-1
3.1 TPM
Tireoide
2.8 TPM
Cólon sigmoide
2.4 TPM
Nervo tibial
2.2 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 14severe early-childhood-onset retinal dystrophyretinitis pigmentosaLeber congenital amaurosis
HGNC:6685UniProt:O95237
IFT172Intraflagellar transport protein 172 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the maintenance and formation of cilia. Plays an indirect role in hedgehog (Hh) signaling, cilia being required for all activity of the hedgehog pathway (By similarity)

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 10 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.3 TPM
Pituitária
51.2 TPM
Ovário
41.6 TPM
Tireoide
30.7 TPM
Cerebelo
30.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 71Bardet-Biedl syndrome 20short-rib thoracic dysplasia 10 with or without polydactylyshort-rib thoracic dysplasia 9 with or without polydactyly
HGNC:30391UniProt:Q9UG01
ABCA4Retinal-specific phospholipid-transporting ATPase ABCA4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leaflet of photoreceptor outer segment disk membranes, where 11-cis-retinylidene-phosphatidylethanolamine is then isomerized to its all-trans isomer and reduced by RDH8 to produce all-trans-retinol. This transport activity ensures that all-trans-retinal generated fr

LOCALIZAÇÃO

MembraneEndoplasmic reticulumCytoplasmic vesicleCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Stargardt disease 1

An autosomal recessive form of Stargardt disease, a retinal degenerative disease characterized by macular dystrophy, progressive bilateral atrophy of the foveal retinal pigment epithelium, and accumulation of fluorescent flecks around the macula and/or in the central and near-peripheral areas of the retina. STGD1 patients typically lose central vision in their first or second decade of life.

OUTRAS DOENÇAS (8)
severe early-childhood-onset retinal dystrophyretinitis pigmentosa 19cone-rod dystrophy 3ABCA4-related retinopathy
HGNC:34UniProt:P78363
PRPF8Pre-mRNA-processing-splicing factor 8Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes, both of the predominant U2-type spliceosome and the minor U12-type spliceosome (PubMed:10411133, PubMed:11971955, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). Functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs. Required for th

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 13

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
202.9 TPM
Útero
179.1 TPM
Linfócitos
178.1 TPM
Cervix Endocervix
167.9 TPM
Cerebelo
156.4 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 13complex neurodevelopmental disorderretinitis pigmentosa
HGNC:17340UniProt:Q6P2Q9
ARL2BPADP-ribosylation factor-like protein 2-binding proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2

LOCALIZAÇÃO

CytoplasmMitochondrion intermembrane spaceCytoplasm, cytoskeleton, microtubule organizing center, centrosomeNucleusCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 82 with or without situs inversus

An autosomal recessive disorder characterized by variable association of retinitis pigmentosa with situs inversus. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. Situs inversus is a congenital abnormality in which organs in the thorax and the abdomen are opposite to their normal positions due to lateral transposition.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
retinitis pigmentosa with or without situs inversusretinitis pigmentosa
HGNC:17146UniProt:Q9Y2Y0
NEK2Serine/threonine-protein kinase Nek2Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Protein kinase which is involved in the control of centrosome separation and bipolar spindle formation in mitotic cells and chromatin condensation in meiotic cells. Regulates centrosome separation (essential for the formation of bipolar spindles and high-fidelity chromosome separation) by phosphorylating centrosomal proteins such as CROCC, CEP250 and NINL, resulting in their displacement from the centrosomes. Regulates kinetochore microtubule attachment stability in mitosis via phosphorylation o

LOCALIZAÇÃO

NucleusNucleus, nucleolusCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle poleChromosome, centromere, kinetochoreChromosome, centromere

VIAS BIOLÓGICAS (9)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Retinitis pigmentosa 67

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
52.5 TPM
Linfócitos
28.8 TPM
Fibroblastos
8.7 TPM
Esôfago - Mucosa
4.5 TPM
Intestino delgado
2.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 67retinitis pigmentosa
HGNC:7745UniProt:P51955
IMPG2Interphotoreceptor matrix proteoglycan 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Chondroitin sulfate- and hyaluronan-binding proteoglycan involved in the organization of interphotoreceptor matrix; may participate in the maturation and maintenance of the light-sensitive photoreceptor outer segment. Binds heparin

LOCALIZAÇÃO

Photoreceptor outer segment membranePhotoreceptor inner segment membraneSecreted, extracellular space, extracellular matrix, interphotoreceptor matrix

MECANISMO DE DOENÇA

Retinitis pigmentosa 56

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Fallopian Tube
0.8 TPM
Rim - Medula
0.7 TPM
Artéria coronária
0.5 TPM
Nervo tibial
0.4 TPM
Baço
0.4 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 56vitelliform macular dystrophy 5retinitis pigmentosaadult-onset foveomacular vitelliform dystrophy
HGNC:18362UniProt:Q9BZV3
NR2E3Photoreceptor-specific nuclear receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Orphan nuclear receptor of retinal photoreceptor cells. Transcriptional factor that is an activator of rod development and repressor of cone development. Binds the promoter region of a number of rod- and cone-specific genes, including rhodopsin, M- and S-opsin and rod-specific phosphodiesterase beta subunit. Enhances rhodopsin expression. Represses M- and S-cone opsin expression

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Enhanced S cone syndrome

Autosomal recessive retinopathy in which patients have increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones. ESCS is also associated with visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration.

EXPRESSÃO TECIDUAL(Baixa expressão)
Próstata
1.3 TPM
Testículo
1.2 TPM
Tireoide
1.0 TPM
Rim - Medula
0.7 TPM
Fallopian Tube
0.6 TPM
OUTRAS DOENÇAS (4)
enhanced S-cone syndromeretinitis pigmentosa 37Goldmann-Favre syndromeretinitis pigmentosa
HGNC:7974UniProt:Q9Y5X4
FAM161AProtein FAM161ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in ciliogenesis

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole

MECANISMO DE DOENÇA

Retinitis pigmentosa 28

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
15.7 TPM
Ovário
10.0 TPM
Pituitária
8.4 TPM
Tireoide
7.0 TPM
Linfócitos
6.5 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 28retinitis pigmentosa
HGNC:25808UniProt:Q3B820
IFT88Intraflagellar transport protein 88 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Positively regulates primary cilium biogenesis (PubMed:17604723). Also involved in autophagy since it is required for trafficking of ATG16L and the expansion of the autophagic compartment

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCell projection, ciliumCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasmCell projection, cilium, flagellumCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (3)
AggrephagyHedgehog 'off' stateIntraflagellar transport
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.2 TPM
Pituitária
15.9 TPM
Tireoide
14.3 TPM
Cervix Endocervix
12.0 TPM
Ovário
11.9 TPM
OUTRAS DOENÇAS (1)
retinitis pigmentosa
HGNC:20606UniProt:Q13099
CNGA1Cyclic nucleotide-gated channel alpha-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of the rod cyclic nucleotide-gated channel. Mediates rod photoresponses at dim light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyperpolar

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 49

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 49retinitis pigmentosa
HGNC:2148UniProt:P29973
PRPF4U4/U6 small nuclear ribonucleoprotein Prp4Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex)

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 70

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
46.9 TPM
Fibroblastos
44.2 TPM
Ovário
29.4 TPM
Testículo
26.3 TPM
Cervix Endocervix
25.1 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 70retinitis pigmentosa
HGNC:17349UniProt:O43172
CA4Carbonic anhydrase 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the reversible hydration of carbon dioxide into bicarbonate and protons and thus is essential to maintaining intracellular and extracellular pH (PubMed:15563508, PubMed:16686544, PubMed:16807956, PubMed:17127057, PubMed:17314045, PubMed:17652713, PubMed:17705204, PubMed:18618712, PubMed:19186056, PubMed:19206230, PubMed:7625839). May stimulate the sodium/bicarbonate transporter activity of SLC4A4 that acts in pH homeostasis (PubMed:15563508). It is essential for acid overload removal f

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Erythrocytes take up oxygen and release carbon dioxideErythrocytes take up carbon dioxide and release oxygenReversible hydration of carbon dioxide
MECANISMO DE DOENÇA

Retinitis pigmentosa 17

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (1)
retinitis pigmentosa
HGNC:1375UniProt:P22748
BEST1Bestrophin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Ligand-gated anion channel that allows the movement of anions across cell membranes when activated by calcium (Ca2+) (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Allows the movement of chloride and hydrogencarbonate (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Found in a partiall

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 2

An autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
vitelliform macular dystrophy 2retinitis pigmentosa 50autosomal dominant vitreoretinochoroidopathyautosomal recessive bestrophinopathy
HGNC:12703UniProt:O76090
RP2Protein XRP2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as a guanine nucleotide dissociation inhibitor towards ADP-ribosylation facto

LOCALIZAÇÃO

Cell membraneCell projection, cilium

VIAS BIOLÓGICAS (1)
Trafficking of myristoylated proteins to the cilium
MECANISMO DE DOENÇA

Retinitis pigmentosa 2

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
19.1 TPM
Pulmão
13.1 TPM
Esôfago - Mucosa
12.9 TPM
Sangue
11.7 TPM
Tecido adiposo
10.3 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 2retinitis pigmentosa
HGNC:10274UniProt:O75695
DHX38Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Probable ATP-binding RNA helicase (Probable). Involved in pre-mRNA splicing as component of the spliceosome (PubMed:29301961, PubMed:9524131)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Transport of Mature mRNA derived from an Intron-Containing TranscriptmRNA 3'-end processingRNA Polymerase II Transcription TerminationmRNA Splicing - Major PathwayDengue Virus-Host Interactions
MECANISMO DE DOENÇA

Retinitis pigmentosa 84

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP84 is an autosomal recessive, early onset form characterized by night blindness by age 4 and complete blindness by age 8. Funduscopy shows severely attenuated retinal vessels, severe macular atrophy, and prominent and deep macular colobomas lacking neuroretinal tissue.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
73.7 TPM
Ovário
73.6 TPM
Útero
70.1 TPM
Linfócitos
62.6 TPM
Cervix Ectocervix
62.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 84retinitis pigmentosa
HGNC:17211UniProt:Q92620
RDH12Retinol dehydrogenase 12Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Retinoids dehydrogenase/reductase with a clear preference for NADP. Displays high activity towards 9-cis, 11-cis and all-trans-retinal. Shows very weak activity towards 13-cis-retinol (PubMed:12226107, PubMed:15865448). Also exhibits activity, albeit with lower affinity than for retinaldehydes, towards lipid peroxidation products (C9 aldehydes) such as 4-hydroxynonenal and trans-2-nonenal (PubMed:15865448, PubMed:19686838). May play an important function in photoreceptor cells to detoxify 4-hydr

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
The canonical retinoid cycle in rods (twilight vision)
MECANISMO DE DOENÇA

Leber congenital amaurosis 13

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
100.3 TPM
Skin Not Sun Exposed Suprapubic
89.6 TPM
Vagina
31.9 TPM
Esôfago - Mucosa
23.1 TPM
Estômago
3.3 TPM
OUTRAS DOENÇAS (3)
Leber congenital amaurosis 13retinitis pigmentosaLeber congenital amaurosis
HGNC:19977UniProt:Q96NR8
ARL6ADP-ribosylation factor-like protein 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in membrane protein trafficking at the base of the ciliary organelle. Mediates recruitment onto plasma membrane of the BBSome complex which would constitute a coat complex required for sorting of specific membrane proteins to the primary cilia (PubMed:20603001). Together with BBS1, is necessary for correct trafficking of PKD1 to primary cilia (By similarity). Together with the BBSome complex and LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 3

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (5)
retinitis pigmentosa 55Bardet-Biedl syndrome 3retinitis pigmentosaBardet-Biedl syndrome
HGNC:13210UniProt:Q9H0F7
SEMA4ASemaphorin-4ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Cell surface receptor for PLXNB1, PLXNB2, PLXNB3 and PLXND1 that plays an important role in cell-cell signaling (By similarity). Regulates glutamatergic and GABAergic synapse development (By similarity). Promotes the development of inhibitory synapses in a PLXNB1-dependent manner and promotes the development of excitatory synapses in a PLXNB2-dependent manner (By similarity). Plays a role in priming antigen-specific T-cells, promotes differentiation of Th1 T-helper cells, and thereby contributes

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Other semaphorin interactions
MECANISMO DE DOENÇA

Retinitis pigmentosa 35

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
85.9 TPM
Linfócitos
67.2 TPM
Tireoide
40.6 TPM
Skin Not Sun Exposed Suprapubic
38.2 TPM
Esôfago - Mucosa
36.5 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 35cone-rod dystrophy 10familial colorectal cancer type Xcone-rod dystrophy
HGNC:10729UniProt:Q9H3S1
IMPDH1Inosine-5'-monophosphate dehydrogenase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (3)
Purine ribonucleoside monophosphate biosynthesisAzathioprine ADMEPotential therapeutics for SARS
MECANISMO DE DOENÇA

Retinitis pigmentosa 10

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
172.5 TPM
Baço
95.6 TPM
Fibroblastos
82.8 TPM
Adipose Visceral Omentum
79.9 TPM
Tecido adiposo
66.9 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 11retinitis pigmentosa 10retinitis pigmentosaLeber congenital amaurosis
HGNC:6052UniProt:P20839
CDHR1Cadherin-related family member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Potential calcium-dependent cell-adhesion protein. May be required for the structural integrity of the outer segment (OS) of photoreceptor cells (By similarity)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Cone-rod dystrophy 15

An autosomal recessive retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (3)
cone-rod dystrophy 15cone-rod dystrophyretinitis pigmentosa
HGNC:14550UniProt:Q96JP9
ZNF513Zinc finger protein 513Disease-causing germline mutation(s) inModerado
FUNÇÃO

Transcriptional regulator that plays a role in retinal development and maintenance

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Retinitis pigmentosa 58

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
74.5 TPM
Pituitária
52.6 TPM
Tireoide
46.9 TPM
Próstata
44.8 TPM
Baço
40.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 58retinitis pigmentosa
HGNC:26498UniProt:Q8N8E2
BBS2BBSome complex member BBS2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 2

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (4)
Bardet-Biedl syndrome 2retinitis pigmentosa 74retinitis pigmentosaBardet-Biedl syndrome
HGNC:967UniProt:Q9BXC9
MERTKTyrosine-protein kinase MerDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by l

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Cell surface interactions at the vascular wallDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Retinitis pigmentosa 38

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
52.4 TPM
Artéria tibial
46.6 TPM
Baço
37.9 TPM
Aorta
33.9 TPM
Testículo
31.7 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 38retinitis pigmentosa
HGNC:7027UniProt:Q12866
RP1L1Retinitis pigmentosa 1-like 1 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the differentiation of photoreceptor cells. Plays a role in the organization of outer segment of rod and cone photoreceptors (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium axonemeCell projection, cilium, photoreceptor outer segment

MECANISMO DE DOENÇA

Occult macular dystrophy

An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina.

EXPRESSÃO TECIDUAL(Baixa expressão)
Skin Sun Exposed Lower leg
0.6 TPM
Skin Not Sun Exposed Suprapubic
0.5 TPM
Pituitária
0.4 TPM
Testículo
0.3 TPM
Vagina
0.3 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (3)
occult macular dystrophyretinitis pigmentosa 88retinitis pigmentosa
HGNC:15946UniProt:Q8IWN7
IMPG1Interphotoreceptor matrix proteoglycan 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Chondroitin sulfate-, heparin- and hyaluronan-binding protein (By similarity). May serve to form a basic macromolecular scaffold comprising the insoluble interphotoreceptor matrix (PubMed:9813076)

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentSecreted, extracellular space, extracellular matrix, interphotoreceptor matrixPhotoreceptor inner segment

MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 4

A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD4 features include late-onset moderate visual impairment, small satellite drusen-like lesions in the foveal area, and preservation of retinal pigment epithelium reflectivity.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Nucleus accumbens basal ganglia
3.2 TPM
Brain Caudate basal ganglia
1.5 TPM
Cerebelo
1.2 TPM
Brain Putamen basal ganglia
1.0 TPM
Brain Frontal Cortex BA9
0.8 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (4)
vitelliform macular dystrophy 4benign concentric annular macular dystrophyretinitis pigmentosaadult-onset foveomacular vitelliform dystrophy
HGNC:6055UniProt:Q17R60
SCAPERS phase cyclin A-associated protein in the endoplasmic reticulumDisease-causing germline mutation(s) inTolerante
FUNÇÃO

CCNA2/CDK2 regulatory protein that transiently maintains CCNA2 in the cytoplasm

LOCALIZAÇÃO

Endoplasmic reticulumNucleus

MECANISMO DE DOENÇA

Intellectual developmental disorder and retinitis pigmentosa

An autosomal recessive disease characterized by mild to moderate intellectual disability, retinitis pigmentosa, and attention deficit-hyperactivity disorder observed in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
16.7 TPM
Cérebro - Hemisfério cerebelar
16.3 TPM
Artéria tibial
15.6 TPM
Cerebelo
14.7 TPM
Pituitária
14.0 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
intellectual developmental disorder and retinitis pigmentosa; IDDRPretinitis pigmentosaBardet-Biedl syndrome
HGNC:13081UniProt:Q9BY12
EYSProtein eyes shut homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required to maintain the integrity of photoreceptor cells (PubMed:18836446). Specifically required for normal morphology of the photoreceptor ciliary pocket, and might thus facilitate protein trafficking between the photoreceptor inner and outer segments via the transition zone (By similarity)

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentCell projection, ciliumCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, microtubule organizing center, centrosomeSecreted, extracellular space, extracellular matrix, interphotoreceptor matrix

MECANISMO DE DOENÇA

Retinitis pigmentosa 25

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.0 TPM
Cerebelo
0.3 TPM
Cérebro - Hemisfério cerebelar
0.2 TPM
Tecido adiposo
0.2 TPM
Cervix Ectocervix
0.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 25retinitis pigmentosa
HGNC:21555UniProt:Q5T1H1
CERKLCeramide kinase-like proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Has no detectable ceramide-kinase activity. Overexpression of CERKL protects cells from apoptosis in oxidative stress conditions

LOCALIZAÇÃO

CytoplasmNucleus, nucleolusGolgi apparatus, trans-Golgi networkEndoplasmic reticulum

MECANISMO DE DOENÇA

Retinitis pigmentosa 26

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 26retinitis pigmentosa
HGNC:21699UniProt:Q49MI3
ARHGEF18Rho guanine nucleotide exchange factor 18Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. Its activation induces formation of actin stress fibers. Also acts as a GEF for RAC1, inducing production of reactive oxygen species (ROS). Does not act as a GEF for CDC42. The G protein beta-gamma (Gbetagamma) subunits of heterotrimeric G proteins act as activators, explaining the integrated effects of LPA and other G-protein coupled receptor agonists on actin stress fiber formation, cell shape change and ROS production. Requi

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCell membraneApical cell membrane

VIAS BIOLÓGICAS (1)
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
MECANISMO DE DOENÇA

Retinitis pigmentosa 78

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP78 inheritance is autosomal recessive.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 78retinitis pigmentosa
HGNC:17090UniProt:Q6ZSZ5
MAKSerine/threonine-protein kinase MAKDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleMidbodyCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

VIAS BIOLÓGICAS (2)
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
MECANISMO DE DOENÇA

Retinitis pigmentosa 62

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
15.1 TPM
Sangue
2.7 TPM
Pituitária
1.8 TPM
Fallopian Tube
1.3 TPM
Baço
1.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 62retinitis pigmentosa
HGNC:6816UniProt:P20794
COQ8BAtypical kinase COQ8B, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:24270420, PubMed:36302899, PubMed:38425362). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (PubMed:38425362). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates a prenyl lipid in the ubiquinone biosynthesis pat

LOCALIZAÇÃO

Mitochondrion membraneCytoplasm, cytosolCell membrane

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Nephrotic syndrome 9

A form of nephrotic syndrome, a renal disease clinically characterized by progressive renal failure, severe proteinuria, hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show focal segmental glomerulosclerosis.

VIAS REACTOME (1)
OUTRAS DOENÇAS (3)
nephrotic syndrome, type 9familial idiopathic steroid-resistant nephrotic syndromeretinitis pigmentosa
HGNC:19041UniProt:Q96D53
SNRNP200U5 small nuclear ribonucleoprotein 200 kDa helicaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the ATP-dependent unwinding of U4/U6 RNA duplices, an essential step in the assembly of a catalytically active spliceosome (PubMed:35241646). Plays a role in pre-mRNA splicing as a core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). As a component of the minor spliceosome, involved in the splicing of U12-type introns in

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 33

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
153.3 TPM
Ovário
132.5 TPM
Útero
119.1 TPM
Cervix Endocervix
112.7 TPM
Cérebro - Hemisfério cerebelar
109.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 33retinitis pigmentosa
HGNC:30859UniProt:O75643
TTC8Tetratricopeptide repeat protein 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteCell projection, cilium

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Retinitis pigmentosa 51

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
40.7 TPM
Pituitária
30.5 TPM
Testículo
20.5 TPM
Glândula adrenal
19.6 TPM
Tireoide
18.3 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 51Bardet-Biedl syndrome 8retinitis pigmentosaBardet-Biedl syndrome
HGNC:20087UniProt:Q8TAM2
TUBTubby protein homologDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Functions in signal transduction from heterotrimeric G protein-coupled receptors. Binds to membranes containing phosphatidylinositol 4,5-bisphosphate. Can bind DNA (in vitro). May contribute to the regulation of transcription in the nucleus. Could be involved in the hypothalamic regulation of body weight (By similarity). Contribute to stimulation of phagocytosis of apoptotic retinal pigment epithelium (RPE) cells and macrophages

LOCALIZAÇÃO

CytoplasmNucleusSecretedCell membrane

VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Retinal dystrophy and obesity

A disease characterized by obesity, night blindness, decreased visual acuity, and electrophysiological features of a rod cone dystrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
71.1 TPM
Cervix Endocervix
69.3 TPM
Cervix Ectocervix
61.5 TPM
Útero
55.9 TPM
Cerebelo
44.2 TPM
OUTRAS DOENÇAS (2)
retinal dystrophy and obesityretinitis pigmentosa
HGNC:12406UniProt:P50607
FSCN2Fascin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as an actin bundling protein. May play a pivotal role in photoreceptor cell-specific events, such as disk morphogenesis

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell projection, stereocilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Retinitis pigmentosa 30

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
9.2 TPM
Pâncreas
3.6 TPM
Útero
2.4 TPM
Fallopian Tube
2.3 TPM
Linfócitos
2.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 30retinitis pigmentosa
HGNC:3960UniProt:O14926
HGSNATHeparan-alpha-glucosaminide N-acetyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Lysosomal acetyltransferase that acetylates the non-reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-N-acetyl glucosaminidase

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
HS-GAG degradation
MECANISMO DE DOENÇA

Mucopolysaccharidosis 3C

A form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
80.4 TPM
Cervix Ectocervix
76.1 TPM
Ovário
71.9 TPM
Nervo tibial
67.3 TPM
Útero
66.7 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (3)
mucopolysaccharidosis type 3Cretinitis pigmentosa 73retinitis pigmentosa
HGNC:26527UniProt:Q68CP4
PRPH2Peripherin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). Required for the correct development and organization of the photoreceptor inner segment (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Ovário
6.8 TPM
Cervix Ectocervix
5.7 TPM
Pituitária
5.3 TPM
Músculo esquelético
5.0 TPM
OUTRAS DOENÇAS (13)
retinitis pigmentosa 7vitelliform macular dystrophy 3fundus albipunctatuschoroidal dystrophy, central areolar 2
HGNC:9942UniProt:P23942
NRLNeural retina-specific leucine zipper proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a transcriptional activator which regulates the expression of several rod-specific genes, including RHO and PDE6B (PubMed:21981118). Also functions as a transcriptional coactivator, stimulating transcription mediated by the transcription factor CRX and NR2E3 (PubMed:17335001). Binds to the rhodopsin promoter in a sequence-specific manner (PubMed:17335001)

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Retinitis pigmentosa 27

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
5.4 TPM
Tireoide
2.8 TPM
Pituitária
2.6 TPM
Brain Spinal cord cervical c-1
2.5 TPM
Rim - Medula
2.1 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 27retinitis pigmentosa
HGNC:8002UniProt:P54845
ROM1Rod outer segment membrane protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in rod outer segment (ROS) morphogenesis (By similarity). May play a role with PRPH2 in the maintenance of the structure of ROS curved disks (By similarity). Plays a role in the organization of the ROS and maintenance of ROS disk diameter (By similarity). Involved in the maintenance of the retina outer nuclear layer (By similarity)

LOCALIZAÇÃO

Photoreceptor inner segment membranePhotoreceptor outer segment membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
56.0 TPM
Substância negra
34.4 TPM
Cérebro - Amígdala
24.2 TPM
Hipocampo
23.2 TPM
Cérebro - Hemisfério cerebelar
22.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 7retinitis pigmentosa
HGNC:10254UniProt:Q03395
KIZCentrosomal protein kizunaDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Centrosomal protein required for establishing a robust mitotic centrosome architecture that can endure the forces that converge on the centrosomes during spindle formation. Required for stabilizing the expanded pericentriolar material around the centriole

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal body

MECANISMO DE DOENÇA

Retinitis pigmentosa 69

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
60.4 TPM
Cervix Endocervix
50.2 TPM
Cervix Ectocervix
38.4 TPM
Ovário
36.5 TPM
Bladder
35.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 69retinitis pigmentosa
HGNC:15865UniProt:Q2M2Z5
CLRN1Clarin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May have a role in the excitatory ribbon synapse junctions between hair cells and cochlear ganglion cells and presumably also in analogous synapses within the retina

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Usher syndrome 3A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH3 is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life.

OUTRAS DOENÇAS (4)
retinitis pigmentosa 61Usher syndrome type 3AUsher syndrome type 3retinitis pigmentosa
HGNC:12605UniProt:P58418
IFT43Intraflagellar transport protein 43 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

As a component of IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs), it is involved in ciliogenesis (PubMed:28400947, PubMed:28973684). Involved in retrograde ciliary transport along microtubules from the ciliary tip to the base (PubMed:21378380)

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell projection, cilium

VIAS BIOLÓGICAS (1)
Intraflagellar transport
MECANISMO DE DOENÇA

Cranioectodermal dysplasia 3

A disorder primarily characterized by craniofacial, skeletal and ectodermal abnormalities. Clinical features include craniosynostosis, narrow rib cage, short limbs, brachydactyly, hypoplastic and widely spaced teeth, sparse hair, skin laxity and abnormal nails. Nephronophthisis leading to progressive renal failure, hepatic fibrosis, heart defects, and retinitis pigmentosa have also been described.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
38.9 TPM
Pituitária
32.1 TPM
Tireoide
31.6 TPM
Fallopian Tube
30.3 TPM
Cervix Endocervix
29.3 TPM
OUTRAS DOENÇAS (5)
cranioectodermal dysplasia 3retinitis pigmentosa 81short-rib thoracic dysplasia 18 with polydactylycranioectodermal dysplasia
HGNC:29669UniProt:Q96FT9
AHRAryl hydrocarbon receptorDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer (PubMed:23275542, PubMed:30373764, PubMed:32818467, PubMed:7961644). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) (PubMed:23275542, PubMed:30

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Aryl hydrocarbon receptor signalling
MECANISMO DE DOENÇA

Retinitis pigmentosa 85

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP85 is an autosomal recessive form manifesting as early-onset progressive difficulty to adapt in dim light and gradually decreasing visual acuity in both eyes.

OUTRAS DOENÇAS (3)
foveal hypoplasia 3retinitis pigmentosa 85retinitis pigmentosa
HGNC:348UniProt:P35869
PDE6ARod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). This protein participates in processes of transmission and amplification of the visual signal

LOCALIZAÇÃO

Cell membraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 43

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.6 TPM
Pituitária
3.1 TPM
Esôfago - Mucosa
1.5 TPM
Cólon transverso
1.1 TPM
Glândula adrenal
0.8 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 43retinitis pigmentosa
HGNC:8785UniProt:P16499
DHDDSDehydrodolichyl diphosphate synthase complex subunit DHDDSDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

With NUS1, forms the dehydrodolichyl diphosphate synthase (DDS) complex, an essential component of the dolichol monophosphate (Dol-P) biosynthetic machinery (PubMed:25066056, PubMed:28842490, PubMed:32817466, PubMed:33077723). Both subunits contribute to enzymatic activity, i.e. condensation of multiple copies of isopentenyl pyrophosphate (IPP) to farnesyl pyrophosphate (FPP) to produce dehydrodolichyl diphosphate (Dedol-PP), a precursor of dolichol phosphate which is utilized as a sugar carrier

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of dolichyl-phosphate
MECANISMO DE DOENÇA

Retinitis pigmentosa 59

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
95.1 TPM
Cérebro - Hemisfério cerebelar
91.4 TPM
Tecido adiposo
33.3 TPM
Fibroblastos
27.0 TPM
Skin Sun Exposed Lower leg
25.7 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 59developmental delay and seizures with or without movement abnormalitiesretinitis pigmentosaundetermined early-onset epileptic encephalopathy
HGNC:20603UniProt:Q86SQ9
PCAREPhotoreceptor cilium actin regulatorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays an essential role for normal photoreceptor cell maintenance and vision

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 54

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 54retinitis pigmentosa
HGNC:34383UniProt:A6NGG8
USH2AUsherinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport

LOCALIZAÇÃO

Cell projection, stereocilium membraneSecreted

MECANISMO DE DOENÇA

Usher syndrome 2A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Fígado
0.8 TPM
Cérebro - Hemisfério cerebelar
0.2 TPM
Cerebelo
0.2 TPM
Coração - Átrio
0.2 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 39Usher syndrome type 2AUsher syndromeretinitis pigmentosa
HGNC:12601UniProt:O75445
PDE6BRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). Necessary for the formation of a functional phosphodiesterase holoenzyme (By similarity). Involved in retinal circadian rhythm photoentrainment via modulation of UVA and orange light-induced phase-shift of the retina clock (By similarity). May participate in processes of transmission and amplification of the visual signal (PubMed:8394174)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 40

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
22.1 TPM
Hipocampo
14.7 TPM
Brain Caudate basal ganglia
14.3 TPM
Brain Nucleus accumbens basal ganglia
13.9 TPM
Substância negra
13.4 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 40congenital stationary night blindness autosomal dominant 2retinitis pigmentosa
HGNC:8786UniProt:P35913
OFD1Centriole and centriolar satellite protein OFD1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the centrioles controlling mother and daughter centrioles length. Recruits to the centriole IFT88 and centriole distal appendage-specific proteins including CEP164 (By similarity). Involved in the biogenesis of the cilium, a centriole-associated function. The cilium is a cell surface projection found in many vertebrate cells required to transduce signals important for development and tissue homeostasis (PubMed:33934390). Plays an important role in development by regulating Wnt signa

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, cilium basal bodyNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (8)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Orofaciodigital syndrome 1

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by abnormalities in the oral cavity, face, and digits and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD1 is X-linked dominant syndrome, lethal in males. Craniofacial findings consist of facial asymmetry, hypertelorism, median cleft, or pseudocleft of the upper lip, hypoplasia of the alae nasi, oral clefts and abnormal frenulea, tongue anomalies (clefting, cysts, hamartoma), and anomalous dentition involving missing or extra teeth. Asymmetric brachydactyly and/or syndactyly of the fingers and toes occur frequently. Approximately 50% of OFD1 females have some degree of intellectual disability. Some patients have structural central nervous system anomalies such as agenesis of the corpus callosum, cerebellar agenesis, or a Dandy-Walker malformation. Patients with OFD1 can develop fibrocystic disease of the liver and pancreas, in addition to polycystic kidneys.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
47.1 TPM
Fallopian Tube
44.0 TPM
Tireoide
42.2 TPM
Cervix Endocervix
39.8 TPM
Útero
36.8 TPM
OUTRAS DOENÇAS (8)
Joubert syndrome 10orofaciodigital syndrome Iretinitis pigmentosa 23Simpson-Golabi-Behmel syndrome type 2
HGNC:2567UniProt:O75665
RBP3Retinol-binding protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

IRBP shuttles 11-cis and all trans retinoids between the retinol isomerase in the pigment epithelium and the visual pigments in the photoreceptor cells of the retina

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, interphotoreceptor matrix

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)The retinoid cycle in cones (daylight vision)
MECANISMO DE DOENÇA

Retinitis pigmentosa 66

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
0.6 TPM
Brain Spinal cord cervical c-1
0.6 TPM
Cérebro - Hemisfério cerebelar
0.5 TPM
Hipocampo
0.5 TPM
Córtex cerebral
0.4 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 66retinitis pigmentosa
HGNC:9921UniProt:P10745

Medicamentos e terapias

VALPROIC ACIDPhase 2

Mecanismo: Succinate semialdehyde dehydrogenase inhibitor

CARBIDOPA ANHYDROUSPhase 2

Mecanismo: DOPA decarboxylase inhibitor

METHOTREXATEPhase 2

Mecanismo: Dihydrofolate reductase inhibitor

LEVODOPAPhase 2

Mecanismo: Dopamine D3 receptor agonist

CARBIDOPAPhase 2

Mecanismo: DOPA decarboxylase inhibitor

HYDROXYCHLOROQUINEPhase 1

Mecanismo: Toll-like receptor 7 antagonist

BRIMONIDINEPhase 1

Mecanismo: Adrenergic receptor alpha-2 agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

548 variantes patogênicas registradas no ClinVar.

🧬 AHI1: NM_001134831.2(AHI1):c.1695_1696insG (p.His566fs) ()
🧬 AHI1: NM_001134831.2(AHI1):c.2053del (p.Glu684_Ile685insTer) ()
🧬 AHI1: NM_001134831.2(AHI1):c.189+1G>T ()
🧬 AHI1: NM_001134831.2(AHI1):c.2373+1G>A ()
🧬 AHI1: NM_001134831.2(AHI1):c.1627-1G>C ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 18,405 variantes classificadas pelo ClinVar.

3681
6442
8282
Patogênica (20.0%)
VUS (35.0%)
Benigna (45.0%)
VARIANTES MAIS SIGNIFICATIVAS
DHDDS: NM_205861.3(DHDDS):c.517del (p.Val173fs) [Pathogenic]
MERTK: NM_006343.3(MERTK):c.1867+1G>A [Likely pathogenic]
MERTK: NM_006343.3(MERTK):c.2424_2432del (p.Glu808_Tyr810del) [Likely pathogenic]
IFT172: NM_015662.3(IFT172):c.2687G>A (p.Trp896Ter) [Pathogenic]
DHDDS: NM_205861.3(DHDDS):c.49G>A (p.Ala17Thr) [Uncertain significance]

Vias biológicas (Reactome)

102 vias biológicas associadas aos genes desta condição.

Anchoring of the basal body to the plasma membrane Synthesis of GDP-mannose Defective HK1 causes hexokinase deficiency (HK deficiency) Glycolysis mRNA Splicing - Major Pathway Trafficking of myristoylated proteins to the cilium SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of immune response proteins RP105:MD1 Citric acid cycle (TCA cycle) Mitochondrial protein degradation Activation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade Ca2+ pathway Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 DAG1 core M2 glycosylations DAG1 core M1 glycosylations Matriglycan biosynthesis on DAG1 RGR Light stimulates opsin receptors Developmental Lineage of Pancreatic Ductal Cells The canonical retinoid cycle in rods (twilight vision) Olfactory Signaling Pathway VxPx cargo-targeting to cilium Hedgehog 'off' state Intraflagellar transport mRNA Splicing - Minor Pathway Dengue Virus-Host Interactions G alpha (i) signalling events Opsins The retinoid cycle in cones (daylight vision) Defective visual phototransduction due to RDH5 loss of function Carboxyterminal post-translational modifications of tubulin RPGRIP1L RAB8A,10,13,14 exchange GDP for GTP Signaling by BRAF and RAF1 fusions BBSome-mediated cargo-targeting to cilium Retinoid metabolism and transport Defective visual phototransduction due to LRAT loss of function ABC-family proteins mediated transport Defective visual phototransduction due to ABCA4 loss of function Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane APC-Cdc20 mediated degradation of Nek2A Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes AURKA Activation by TPX2 GSK3B-mediated proteasomal degradation of PD-L1(CD274) Nuclear Receptor transcription pathway Chaperone Mediated Autophagy Late endosomal microautophagy Aggrephagy Erythrocytes take up carbon dioxide and release oxygen Erythrocytes take up oxygen and release carbon dioxide Reversible hydration of carbon dioxide Stimuli-sensing channels Defective visual phototransduction due to RDH12 loss of function Other semaphorin interactions Neutrophil degranulation Purine ribonucleoside monophosphate biosynthesis Potential therapeutics for SARS Azathioprine ADME Cell surface interactions at the vascular wall Dengue Virus Attachment and Entry Essential pentosuria NRAGE signals death through JNK TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) G alpha (12/13) signalling events RHOA GTPase cycle RAC1 GTPase cycle NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Diseases of branched-chain amino acid catabolism PTEN Regulation Regulation of PTEN gene transcription FCERI mediated NF-kB activation TP53 Regulates Metabolic Genes Stabilization of p53 Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) Regulation of TP53 Activity through Phosphorylation TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Ubiquinol biosynthesis Infection with Mycobacterium tuberculosis Post-chaperonin tubulin folding pathway Formation of tubulin folding intermediates by CCT/TriC Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea HS-GAG degradation MPS IIIC - Sanfilippo syndrome C Transphosphorylation of pLIMK1 PPARA activates gene expression Phase I - Functionalization of compounds Endogenous sterols Xenobiotics Aryl hydrocarbon receptor signalling Synthesis of dolichyl-phosphate Defective DHDDS causes RP59

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 33
2Fase 214
1Fase 13
·Pré-clínico7
Medicamentos catalogadosEnsaios clínicos· 7 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Retinite pigmentosa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

14 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

313 ensaios clínicos encontrados, 40 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Ensaio randomizado
Timeline de publicações
5.467 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 5.467

#1

Functional Validation of a Novel Deep Intronic IMPG2 Variant Causing Pseudoexon Activation in Retinitis Pigmentosa with Macular Involvement.

The application of clinical genetics2026

Este estudo identificou uma nova variante genética, localizada profundamente numa região não-codificante (intrônica) do gene IMPG2, como causa de Retinose Pigmentar (RP) com envolvimento macular. Essa variante provoca um erro no processamento genético, resultando na ativação de um "pseudoéxon" e na consequente falha na produção da proteína funcional. Para pacientes e médicos, esta descoberta é crucial porque expande o espectro de causas genéticas da RP, justificando a busca por essas variantes "ocultas" em casos sem diagnóstico e sublinhando a importância de testes funcionais para confirmar sua patogenicidade.

🇧🇷 traduzido
#2

Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation.

Stem cell research2026 Mar 16

Um estudo recente conseguiu gerar uma linhagem de células-tronco pluripotentes induzidas (iPSCs) a partir de células sanguíneas de uma paciente chinesa com Retinose Pigmentar (RP) e uma mutação específica no gene PRPF31. Essa linhagem de iPSCs, por ser específica da paciente, oferece uma ferramenta valiosa para compreender os mecanismos exatos da doença e acelerar a busca por tratamentos mais eficazes e personalizados para a RP associada ao PRPF31.

🇧🇷 traduzido
#3

Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science2026 Mar 02

A Retinose Pigmentar (RP), uma doença ocular que causa perda progressiva da visão e sem terapias eficazes atuais, foi ligada à ferroptose – um tipo de morte celular – como um motor crítico da disfunção das células do epitélio pigmentar da retina (RPE), especialmente na forma deficiente em MERTK. O estudo demonstrou que a inibição da ferroptose restaurou a função fagocítica das células RPE em modelos pré-clínicos, sugerindo que mirar na ferroptose pode ser uma promissora estratégia terapêutica para pacientes com RP deficiente em MERTK.

🇧🇷 traduzido
#4

A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization.

International journal of molecular sciences2026 Mar 03

Este estudo identificou uma nova variante no gene ARL3 como causa de Retinose Pigmentar (RP) não sindrômica. O ponto mais relevante para pacientes e médicos é a **grande variabilidade clínica**: indivíduos da mesma família com a variante podem apresentar desde atrofia retiniana severa até a ausência total de sintomas, independentemente da idade. Isso ressalta a importância de combinar testes genéticos com validação funcional para um diagnóstico preciso e um melhor aconselhamento, já que a presença da mutação não garante a manifestação ou a gravidade da doença.

🇧🇷 traduzido
#5

Formyl peptide receptors as therapeutic targets in eye disease.

Trends in pharmacological sciences2026 Mar 11

Os receptores de peptídeos formilados (FPRs) são agora reconhecidos como importantes reguladores da saúde ocular, com capacidade de tanto agravar quanto promover a recuperação em doenças como a Retinopatia Pigmentosa. Para pacientes e médicos, isso aponta para uma nova e promissora via terapêutica. O objetivo é modular seletivamente esses FPRs para direcionar sua ação para o reparo e tratamento da doença, oferecendo esperança para intervenções futuras.

🇧🇷 traduzido

Publicações recentes

Ver todas no PubMed

📚 EuropePMC5.506 artigos no totalmostrando 200

2026

Functional Validation of a Novel Deep Intronic IMPG2 Variant Causing Pseudoexon Activation in Retinitis Pigmentosa with Macular Involvement.

The application of clinical genetics
2026

Conformational signatures of native ligand and pharmacochaperone binding in rhodopsin.

bioRxiv : the preprint server for biology
2026

Crop-OCT: a Fully Integrated Imageomics Pipeline to Identify Regional and Focal Retinopathy in Murine Models.

bioRxiv : the preprint server for biology
2025

Genetic and clinical characterization of suspected retinitis pigmentosa in a cohort of Brazilian patients.

Molecular vision
2025

The genotype-phenotype association of retinitis pigmentosa in a Chinese population: Analysis of three new cases and literature review.

Molecular vision
2026

Retinal gene therapies for inherited ocular diseases: Translational delivery strategies from bench to bedside.

Journal of controlled release : official journal of the Controlled Release Society
2026

Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation.

Stem cell research
2026

Nutritional supplements: current evidence for retinitis pigmentosa and Stargardt disease.

Current opinion in ophthalmology
2026

Mapping the intellectual landscape and emerging trends of retinitis pigmentosa research.

Frontiers in medicine
2025

Meckel-Gruber syndrome: a rare and fatal congenital disorder (case report).

The Pan African medical journal
2026

Electroretinographic patterns of retinitis pigmentosa in a Palestinian cohort: a clinical and functional characterization.

BMC ophthalmology
2026

Publisher Correction: X-Linked Retinitis Pigmentosa (XLRP): An Investigation of the Impact of XLRP on Health-Related Quality of Life of Carers in Great Britain.

Advances in therapy
2026

Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2026

[Results of the multicenter study "Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)". Report 2. Clinical, social and demographic characteristics of inherited retinal pathologies].

Vestnik oftalmologii
2026

[Results of the multicenter study "Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)". Report 1. Molecular genetic characteristics of inherited retinal pathologies].

Vestnik oftalmologii
2026

New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2026

A heterozygous pathogenic RPE65 variant phenocopies a mitochondrial retinopathy.

Ophthalmic genetics
2026

Socioeconomic impact assessment of low vision and blindness on patients and households in Thailand.

Clinical &amp; experimental optometry
2026

A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization.

International journal of molecular sciences
2026

Living with Retinitis Pigmentosa in Türkiye: Diagnosis, Independence, and Access to Care.

Healthcare (Basel, Switzerland)
2026

Systemic and Ocular Manifestations of a Ciliopathy: A Case Report of Renal-Retinal Involvement in Senior-Loken Syndrome.

Journal of clinical medicine
2026

Validation of a novel multi-luminance shape discrimination test for assessment of functional vision.

Documenta ophthalmologica. Advances in ophthalmology
2026

Formyl peptide receptors as therapeutic targets in eye disease.

Trends in pharmacological sciences
2026

Expanding the Clinical Spectrum of Bardet-Biedl Syndrome: Chronic Liver Disease in an Adult Patient.

Cureus
2026

AAV-mediated gene replacement therapy for LRAT-associated retinitis pigmentosa: a proof-of-concept study in a patient-based rat model.

Gene therapy
2026

The EH Binding protein EHBP1 operates in a ciliary functional module affected by INPP5E dysfunction.

Journal of cell science
2026

Compound heterozygous mutations in the USH2A gene causing non-syndromic retinitis pigmentosa.

Ophthalmic genetics
2026

Influence of the design parameters of floor-level guidance lights under a restricted field of view.

Disability and rehabilitation. Assistive technology
2026

Enhancing Experience-Dependent Plasticity Accelerates Vision Loss in a Murine Model of Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2026

Dynamic transcriptomic remodeling in grafted human neural progenitor cells uncovers mechanisms for vision preservation in a rat model of retinitis pigmentosa.

Nature communications
2026

[Remodeling of the internal retina-Implications for targeted optogenetics].

Die Ophthalmologie
2026

A Rare RHO Variant and Its Phenotypic Spectrum in a Portuguese Family with Retinitis Pigmentosa: A Case Series.

Case reports in ophthalmology
2026

Two novel genetic associations with sector retinitis pigmentosa: USH2A and PRPF31.

Ophthalmic genetics
2026

Application of smooth OWA operators to classification of retinitis pigmentosa.

Scientific reports
2026

Multimodal imaging of retinitis pigmentosa associated with optic disc astrocytic hamartoma in one eye and optic disc drusen in the fellow eye: Case report and review of the literature.

Journal francais d'ophtalmologie
2026

[Vitreous cysts in retinitis pigmentosa : A clinicopathological correlation].

Die Ophthalmologie
2026

Phagocytosis by retinal pigment epithelium and microglia does not affect vision restoration by P3HT nanoparticles in Retinitis pigmentosa.

Cell death &amp; disease
2026

G-protein activation of the dark-state conformation of the visual G protein-coupled receptor rhodopsin by releasing critical structural constraints.

Communications biology
2026

RGR-mediated photopic visual cycle and oxidative stress: potential mechanisms for cone vision impairment and retinal degeneration in retinitis pigmentosa linked to D1080N-IRBP.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2026

Social and subjective representations of visual impairment in Italy: a qualitative study.

BMJ paediatrics open
2026

Efficacy and Safety of Gene Therapy for RPGR Gene-Associated X-Linked Retinitis Pigmentosa: A Systematic Review and Meta-Analysis.

Translational vision science &amp; technology
2026

Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2025

Visible light optical coherence tomography for assessing retinal structure and function in diseased mouse models.

Biomedical optics express
2026

A Case of Knobloch Syndrome With Lens Dislocation Resembling Homocystinuria.

Clinical case reports
2026

Generation of the induced pluripotent stem cell line BTHBIOi002-A derived from a USH2 patient with c.2512C>T and c.2802T>G mutations in USH2A gene.

Stem cell research
2026

Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.

BMJ open
2026

Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter Study.

Clinical &amp; experimental ophthalmology
2026

Nonsense Mutation in USH2A Exon-13 Activates the Innate Immune Response in Müller Glial Cells.

International journal of molecular sciences
2026

Functional and Structural Analysis of the Central Retina According to the Fundus Autofluorescence Pattern in Patients with Retinitis Pigmentosa.

Diagnostics (Basel, Switzerland)
2026

Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence.

Survey of ophthalmology
2026

Pathology of the Human Temporal Bone in a Rare Case of Combined Usher Syndrome and Cystic Fibrosis.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2026

The Role of Autophagy-Lysosomal Pathways in Photoreceptor Death in the rd10 Mouse Model of Inherited Retinal Degeneration.

Cells
2026

Visualization analysis of the use of traditional Chinese medicine in the diagnosis and treatment of rare diseases in mainland China based on CiteSpace.

Intractable &amp; rare diseases research
2026

Loss-of-function variants in SAXO6, encoding a microtubule inner protein of photoreceptor cilia, cause a late-onset retinal dystrophy.

American journal of human genetics
2026

Recent Progress in Selenium Nanomedicines for Ocular Diseases.

International journal of nanomedicine
2026

Altered anterior segment biometrics in cataract patients with retinitis pigmentosa: a propensity-matched analysis suggests patterns of zonular weakness.

PeerJ
2026

PRPF8-associated retinitis pigmentosa variant induces human neural retina-autonomous photoreceptor defects.

Scientific reports
2026

Streamlining the diagnostic and management pathways of patients with retinitis pigmentosa.

Ophthalmic genetics
2026

From Sound to Stability: Lessons Learned From the CRUSH Study on Hearing Loss Progression and Vestibular Phenotype in Usher Syndrome Type 2A.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2026

Outcomes of phaco-goniosynechialysis surgery for refractory acute primary angle-closure glaucoma after trabeculectomy complicated by low corneal endothelial cell density.

International ophthalmology
2026

CDHR1 variants in a Japanese family with inherited retinal dystrophy and intrafamilial phenotypic variability.

Frontiers in ophthalmology
2026

Mental health outcomes in patients with inherited retinal diseases: a systematic review and meta-analysis.

International journal of retina and vitreous
2026

Bi-allelic variants in FSD1L cause retinitis pigmentosa with or without neurological involvement.

American journal of human genetics
2026

Perimetry of the Central Visual Field Using a Head-Mounted Open-Source Perimeter in Patients with Inherited Retinal Diseases.

Vision (Basel, Switzerland)
2026

Visual Field Estimation in X-Linked Retinitis Pigmentosa Associated with Retinitis Pigmentosa GTPase Regulator (RPGR) from Image Analysis Using Artificial Intelligence.

Ophthalmology science
2026

Expanding the clinical and genetic spectrum of RHO-associated retinitis pigmentosa.

Experimental biology and medicine (Maywood, N.J.)
2026

A Tripartite AAV System with Engineered Lox Sites Enables Efficient Delivery of the EYS Gene for Retinal Gene Therapy.

Human gene therapy
2026

Establishment of a human induced pluripotent stem cell line (BTHBIOi005-A) from a retinitis pigmentosa patient with a MERTK gene mutation.

Stem cell research
2026

CDH23-associated Usher syndrome: genotype-phenotype correlations.

Ophthalmic genetics
2026

Unveiling ZNF124 as a novel determinant in neurodegeneration: orchestration of photoreceptor homeostasis through MSX2 transcriptional regulation.

Cell death &amp; disease
2026

[Optogenetic reactivation of dormant cone photoreceptors].

Die Ophthalmologie
2026

Valuing Maintenance of Visual Function in Retinitis Pigmentosa: A Discrete Choice Experiment with Patients and the General Public.

PharmacoEconomics - open
2026

Disease progression in IMPDH1 gene-associated rod-cone dystrophy caused by a rare p.Thr244Pro heterozygous variant.

Documenta ophthalmologica. Advances in ophthalmology
2026

Temporal modulation of microglial repopulation attenuates retinal degeneration in retinitis pigmentosa.

Neurobiology of disease
2026

Novel explant model for human retinal progenitor cell transplantation.

Biochemical and biophysical research communications
2026

Aldehyde reductase as potential measurement for retinitis pigmentosa: A two-sample Mendelian randomization (MR) study.

Medicine
2026

X-Linked Retinitis Pigmentosa (XLRP): An Investigation of the Impact of XLRP on Health-Related Quality of Life of Carers in Great Britain.

Advances in therapy
2026

RPGRorf15 nanopore long-read sequencing improves retinitis pigmentosa molecular diagnosis for men and women.

Human genetics
2026

Targeted RNA Degradation by RIBOTACs: A Novel Therapeutic Avenue for Ophthalmic Diseases.

International journal of molecular sciences
2026

Generation and characterization of iPSC lines (SPPHIi005-A, SPPHIi006-A, SPPHIi007-A) from a CRB1-mutation associated retinitis pigmentosa family.

Stem cell research
2026

Increased Gut Microbiota Diversity in Patients With Retinitis Pigmentosa and Implications for Disease Phenotypes and Progression.

Investigative ophthalmology &amp; visual science
2026

Tubulin hyperglutamylation causes retinal degeneration by impairing the structural integrity of cilia and protein mistrafficking.

Zoological research
2026

Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol.

BMJ open
2026

A gel-forming antioxidant eye drop for photoreceptor protection in retinitis pigmentosa.

Drug delivery and translational research
2026

Assessing Agreement between Blue-Light and Green-Light Autofluorescence of Macular Hyperautofluorescent Rings in Inherited Retinal Diseases.

Ophthalmology science
2026

AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.

Molecular therapy : the journal of the American Society of Gene Therapy
2026

Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response.

Scientific reports
2026

Crosstalk Between R-Loops, RNA/DNA Modifications, and Cell Death Dynamics in Canine Models of Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2026

Poly(ADP-ribose) polymerase regulates transient receptor potential channel M2-dependent calpain activation in rd1 mouse retinal degeneration.

Neural regeneration research
2026

Corrigendum to "Generation of three human induced pluripotent stem cell lines from retinitis pigmentosa 25 patient and two carriers but asymptomatic daughters". [Stem. Cell Res. 82 (2025) 103645].

Stem cell research
2026

Non-Neoplastic Disorders Mimicking Anterior Uveitis.

Ocular immunology and inflammation
2026

Correlations between Spectral Domain Optical Coherence Tomography Measurements and Visual Acuity in Patients with Retinitis Pigmentosa at Baseline and One-Year Follow-Up.

Ophthalmic research
2026

Identification and validation of a novel ferroptosis-related gene signature associated with inherited retinal degeneration in Rd10 mice.

Scientific reports
2026

Pathogenicity and Functional Analysis of Multi-Variant Allele of RPE65 Causing Retinitis Pigmentosa.

Translational vision science &amp; technology
2026

Novel Genotype-Phenotype Correlations in CRB1-Retinopathies: Insights from Isoforms and Protein Domains Linked to Disease Severity.

Ophthalmology science
2026

Photonic biosensing and optogenetic technologies: Emerging therapeutic strategies in neurodegenerative diseases.

Neural regeneration research
2026

Ocular delivery of different valosin-containing protein (VCP) inhibitory formulations prevents retinal degeneration in rho∆I255 mice.

Journal of controlled release : official journal of the Controlled Release Society
2026

Brain-computer interface commercialization.

Journal of neuroengineering and rehabilitation
2026

Ultra-high resolution OCT imaging reveals retinal layer degeneration in RD10 mice with comparison to commercial standard resolution OCT.

Scientific reports
2026

Female sex is a risk factor for exacerbated lipid peroxidation and disease in murine retinitis pigmentosa.

Redox biology
2026

Overcoming size barriers in retinal gene therapy via lipid nanoparticle-mediated delivery of full-length eys DNA.

Drug delivery and translational research
2026

[Clinical and genetic aspects of inherited retinal dystrophies : Phenotypic and molecular characterization of 1000 IRD patients in a German tertiary referral center].

Die Ophthalmologie
2026

Targeting AKT via SC79 for Photoreceptor Preservation in Retinitis Pigmentosa Mouse Models.

Biomedicines
2025

Single-Cell Transcriptomics on PRPF31-Mutated Retinal Organoids Reveal Early Müller Glial Activation and Progressive Photoreceptor Degeneration.

Biomedicines
2026

Nasal Retinal Degeneration Is a Feature of a Subset of CRX-Associated Retinopathies.

Genes
2026

RNA Sequencing and Targeted Knockdown Reveal miR-142a-5p as a Driver of Retinal Degeneration in rd1 Mice.

Biology
2026

A Spectrum of Severity of a Unifying Retinal Phenotype in TUBB4B-Associated Inherited Retinal Degeneration.

Retinal cases &amp; brief reports
2026

A Novel N-Terminal PRPF6 Variant in Autosomal Dominant Retinitis Pigmentosa.

Clinical case reports
2026

A novel EYS c.6192-1G>A variant presents ideal base editing therapeutic opportunities.

Ophthalmic genetics
2026

Content Validity of Two Generic Preference-Based Measures in Retinitis Pigmentosa, Including X-Linked Retinitis Pigmentosa.

PharmacoEconomics - open
2026

Compensatory Interplay Between Clarin-1 and Clarin-2 Deafness-Associated Proteins Governs Phenotypic Variability in Hearing.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2026

Modulation of Aerobic Glycolysis Genes During the Progression of Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2025

Prevention and early intervention screening for inherited ocular diseases in Saudi Arabia: a national perspective.

Frontiers in ophthalmology
2026

Clinical Characteristics and Genetic Factors in Retinitis Pigmentosa: A Retrospective Analysis of a Turkish Patient Cohort.

Medical sciences (Basel, Switzerland)
2026

Early Rod Dysfunction Influences Cone Development in a Rhodopsin P23H Mouse Model of Retinitis Pigmentosa.

Pathophysiology : the official journal of the International Society for Pathophysiology
2026

Retained cone-responses in homozygous start codon variant in KIZ-associated retinitis pigmentosa.

Documenta ophthalmologica. Advances in ophthalmology
2025

Retinitis pigmentosa and sensorineural deafness associated with a de novo DHX16 mutation: case report.

Frontiers in genetics
2026

Clinical and genetic characterization of REEP6-associated retinopathy in a Japanese cohort.

Japanese journal of ophthalmology
2026

Anatomy- versus Sensitivity-Based Loci Preselection in Detecting USH2A-Retinopathy Microperimetric Progression.

Ophthalmology science
2025

Retinal Degeneration and Visual Outcomes in Patients With Bardet-Biedl Syndrome: Genotypic Influences From a Caribbean Cohort.

Cureus
2026

Patient perspectives on clinical environment accessibility: a qualitative study in severe vision loss.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2026

Targeting the CCL7-STAT1 axis attenuates microglial neurotoxicity and photoreceptor degeneration in retinitis pigmentosa.

Journal of neuroinflammation
2026

Corrigendum to 'Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy' [Genes Dis (12) (2025) 101609].

Genes &amp; diseases
2026

Genotypic and phenotypic landscape of novel RPGR variants in patients from Western Canada.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2026

Reclassification of a novel NR2E3 variant as likely pathogenic: a case report of autosomal recessive RP37 in siblings.

Ophthalmic genetics
2026

Key optogenetic advances in retinal prostheses: A comparative narrative review.

Brain research
2026

Calpain-1 C2L domain peptide protects retinal photoreceptor cells in rhodopsin P347L transgenic rabbits.

Experimental eye research
2026

Generation of an induced pluripotent stem cell (iPSC) line (IPSCi001-A), from a 40-year-old female patient with occult macular dystrophy carrying the c.133C > T mutation in the RP1L1 gene.

Stem cell research
2025

Dynamic Inner Blood Retina Barrier Disruption in Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2026

PRPF8 Mutation-Induced Defects in Human iPSC-Derived RPE Are Rescued by Adenine Base Editing.

Investigative ophthalmology &amp; visual science
2026

Exploring extracellular vesicle MicroRNAs in Usher syndrome type 1B: Tear-Derived EVs as potential indicators of retinal health.

Cellular and molecular life sciences : CMLS
2025

Corrigendum: Optical coherence tomography angiography characteristics of microvascular retinal alterations and the relationship with visual impairment in different patterns of retinitis pigmentosa.

Taiwan journal of ophthalmology
2025

Corrigendum: Metabolic rescue of cone photoreceptors in retinitis pigmentosa.

Taiwan journal of ophthalmology
2026

CRISPR-Cas9-Generated TXNDC15 c.560delA Homozygous Mouse Model Exhibits Meckel-Gruber Syndrome Phenotype.

Genesis (New York, N.Y. : 2000)
2025

Early Detection of Cystoid Macular Edema in Retinitis Pigmentosa Using Longitudinal Deep Learning Analysis of OCT Scans.

Diagnostics (Basel, Switzerland)
2026

Safety and neuroprotective efficacy of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo study.

BMC medicine
2026

Inherited retinal disorders in Scotland: A 5 year assessment.

Eye (London, England)
2026

De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa.

Nature genetics
2026

Protection of GAP-43 gene-modified bone marrow mesenchymal stem cells on retinitis pigmentosa.

Journal of translational medicine
2026

Leveraging large scale deep learning models for diagnosis and visual outcome prediction in retinitis pigmentosa.

NPJ digital medicine
2026

Research progress on glycolytic reprogramming in ophthalmic diseases.

PeerJ
2026

High-altitude retinopathy with isolated ellipsoid zone loss: a case report.

Documenta ophthalmologica. Advances in ophthalmology
2026

Early Onset Inherited Retinal Diseases: Characterizing Clinical Manifestations and Common Involved Genes.

Retina (Philadelphia, Pa.)
2026

A unique case of microspherophakia in adult Refsum disease.

American journal of ophthalmology case reports
2026

Comprehensive transcriptomic analysis reveals canonical and novel pathways modulated by nanoceria in mammalian retinal degeneration.

Scientific reports
2026

New Insights into Imaging Patterns of Autoimmune Retinopathies: A Cluster-Based Update.

American journal of ophthalmology
2026

Advances in RPGR gene therapy for X‑linked retinitis pigmentosa: From preclinical insights to clinical application (Review).

International journal of molecular medicine
2025

Novel developments in retinal regeneration: Advances and future outlooks in stem cell therapy.

World journal of stem cells
2025

Efficient derivation of hiPSC-derived photoreceptor precursor cells and their neuroprotective effects in retinal degeneration.

iScience
2025

Integrating Human Expertise With Artificial Intelligence (AI) Models for Optical Coherence Tomography (OCT) Retinal Fluid and Pathology Quantification: A Systematic Review.

Cureus
2025

Expanding the Genetic Spectrum in IMPG1 and IMPG2 Retinopathy.

Genes
2025

Exploring the Genetic Causes of Nonsyndromic Retinal Dystrophies in Qatar.

Genes
2025

Mechanisms and Functions of Chromophore Regeneration in the Classical Visual Cycle: Implications for Retinal Disease Pathogenesis and Therapy.

Biomolecules
2025

Exome sequencing identifies novel genetic variants in patients with atypical Non-Syndromic retinitis pigmentosa.

Molecular biology reports
2026

Atypical Retinitis Pigmentosa With Macular Sparing in a Patient With Compound Heterozygous ABCA4 Variants: A Case Report and Diagnostic Challenge.

Clinical case reports
2026

Age-Stratified Genetic Spectrum of Retinitis Pigmentosa in Korean Patients: Predominance of RPGR Variants in Early-Onset Disease.

Annals of laboratory medicine
2025

The Effect of Tinted Filters on the Visual Function of Patients with Retinitis Pigmentosa.

Journal of ophthalmic &amp; vision research
2026

Natural History of CNGA1-Associated Retinitis Pigmentosa in a Large Chinese Cohort Revealing an Optimal Intervention Window.

American journal of ophthalmology
2025

Detection of cystoid macular edema in patients with retinitis pigmentosa based on deep learning.

International journal of retina and vitreous
2026

Hybrid optogenetic and electrical stimulation of retinal ganglion cells for artificial vision.

Brain stimulation
2025

Estrogen receptor 1 activation suppresses microglia-derived Tnf-α signaling as a photoreceptor self-protection mechanism.

Journal of neuroinflammation
2026

Capsular Tension Ring Implantation Improves Intraocular Lens Power Prediction Accuracy in Cataract with Retinitis Pigmentosa.

Ophthalmology and therapy
2025

PARP Activity Is Essential for Retinal Photoreceptor Survival in the Human Homologous RhoI255del Mouse Model for Autosomal Dominant Retinitis Pigmentosa.

Journal of neurochemistry
2026

Targeting the Spliceosomal Protein USP39 Through Allosteric Ligands and PROTAC-Induced Degradation.

Angewandte Chemie (International ed. in English)
2025

A de novo splice-site variant in the retinitis pigmentosa 2 (RP2) gene identified in a symptomatic carrier woman.

Ophthalmic genetics
2025

SING IMT telescopic intraocular lens implantation in a patient with inverse retinitis pigmentosa: A case report.

American journal of ophthalmology case reports
2025

Preclinical Study on the Long-Term Efficacy and Safety of Sustained-Release Gas6 Liposomes Combined With MERTK Gene Therapy for Retinitis Pigmentosa.

Translational vision science &amp; technology
2025

Redefining cell death: ferroptosis as a game-changer in ophthalmology.

Frontiers in immunology
2025

Breach and restoration of retinal immune privilege: barrier failure, innate dysregulation, and adaptive autoimmunity.

Frontiers in immunology
2025

Differential effects of HDAC inhibitors in the RhoI255d mouse model for autosomal dominant retinitis pigmentosa.

Cell death discovery
2025

Aqueous Humor Exosomal Membrane Proteins: Decoding Pathogenic Molecular Signatures in Retinitis Pigmentosa.

Translational vision science &amp; technology
2025

Retinal Impairments in Mice Lacking Both Nxnl1 and Nxnl2 Genes.

Investigative ophthalmology &amp; visual science
2026

A congenic C57BL/6J rd1 mouse model for retinal degeneration research.

Experimental eye research
2026

APD-based rod cell model with integrated ion channel mechanisms for investigating the ERG a-wave and retinal diseases.

Free radical biology &amp; medicine
2025

Ubap1l Knockout Mice Model Recapitulates Retinal Degeneration Phenotype Observed in Patients and Exhibits Irregular Photoreceptor Morphology.

Investigative ophthalmology &amp; visual science
2025

Deep Learning Detection of Retinitis Pigmentosa Inheritance Forms through Synthetic Data Expansion of a Rare Disease Dataset.

Research square
2025

Retinal organoids mirror CRISPR-Cas9 gene editing efficiency observed in vivo.

Molecular therapy. Methods &amp; clinical development
2025

Lipid nanoparticle mediated base editing of the Q344X rhodopsin mutation associated with retinitis pigmentosa.

Gene therapy
2025

Stem cell therapy for inherited retinal diseases: Trends and insights from 2000 to 2024.

Cell transplantation
2025

Zonular compromise: A narrative review of indicators and management strategies.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2026

MODELING NATURAL HISTORY AND COST-EFFECTIVENESS OF GENE-AGNOSTIC TREATMENT IN RETINITIS PIGMENTOSA.

Retina (Philadelphia, Pa.)
2025

Further evidence for a wide phenotypic and mutational spectrum of Cohen syndrome: case report and literature review.

Journal of applied genetics
2025

A self-supervised learning method for detection of retinitis pigmentosa and Stargardt disease.

Scientific reports
2025

Therapeutic Potential of Partial Retinoid Agonists against Vertebrate Rhodopsin Misfolding Disorders.

ACS omega
2025

Clinical characteristics of EYS-associated retinal dystrophy in 291 Japanese patients.

NPJ genomic medicine
2026

Small nuclear RNA genes in Mendelian disorders.

Nature genetics
2026

Longitudinal Changes in Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Retinitis Pigmentosa.

Ophthalmology science
2025

Application of Machine Learning to Discriminate Photoreceptor Cell Species in Xenotransplanted Chimeric Retinas.

Clinical and translational science
2025

A Case of Retinopathy-Sensory Neuropathy Syndrome With a Novel Compound Heterozygous FLVCR1 Variant.

Journal of the peripheral nervous system : JPNS
2025

Retinal Pigment Epithelium Extracellular Vesicles Induce Microglia Polarization in MERTK-Associated Retinal Degeneration.

Investigative ophthalmology &amp; visual science
2025

Presynaptic Changes in Mouse Rod Photoreceptors During Early Retinitis Pigmentosa.

Investigative ophthalmology &amp; visual science
2025

A human-specific RPGR isoform and a clinically approved Rho/ROCK inhibitor ameliorate defects associated with RPGR dysfunction.

Molecular therapy. Nucleic acids
2025

Cell-based regenerative therapy for retinal diseases: challenges and emerging bioengineering strategies.

Regenerative therapy
2025

Atypical Retinitis Pigmentosa With Systemic Features in Bardet-Biedl Syndrome.

Clinical case reports
2025

Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.

Frontiers in genetics
2025

Disease burden associated with X-linked retinitis pigmentosa in Canada: a retrospective chart review study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

Structural and vascular features of the retina and choroid with retinitis pigmentosa imaged using ultra-widefield swept-source optical coherence tomography angiography.

International ophthalmology
2025

Novel Compound Heterozygous Variants in the TCTN2 Gene Causing Meckel-Gruber Syndrome 8 in a Non-Consanguineous Chinese Family.

Molecular genetics &amp; genomic medicine
2025

Evaluation of the artificial intelligence chatbots in frequently asked questions about retinitis pigmentosa: a comparative analysis between ChatGPT-4 and Gemini-2.0.

International journal of retina and vitreous
2025

Senior-Løken syndrome with IQCB1/NPHP5 mutation in an adult: a case report.

Journal of medical case reports
Ver todos os 5.506 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Retinite pigmentosa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Retinite pigmentosa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Functional Validation of a Novel Deep Intronic IMPG2 Variant Causing Pseudoexon Activation in Retinitis Pigmentosa with Macular Involvement.
    The application of clinical genetics· 2026· PMID 41868382mais citado
  2. Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation.
    Stem cell research· 2026· PMID 41864154mais citado
  3. Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41848364mais citado
  4. A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization.
    International journal of molecular sciences· 2026· PMID 41828587mais citado
  5. Formyl peptide receptors as therapeutic targets in eye disease.
    Trends in pharmacological sciences· 2026· PMID 41820155mais citado
  6. Elevating Jak-STAT signaling via SOCS3 deletion sustains photoreceptor viability and visual function in mouse models of retinitis pigmentosa.
    Cell Commun Signal· 2026· PMID 41992230recente
  7. A novel CEP78 variant and rod-cone dystrophy in non-consanguineous siblings.
    Ophthalmic Genet· 2026· PMID 41991503recente
  8. RNA interference to reduce Egr1 expression in rods delays retinal degeneration in a model of retinitis pigmentosa.
    Mol Vis· 2026· PMID 41982462recente
  9. Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial.
    Nat Med· 2026· PMID 41981307recente
  10. Persistent Bilateral Optic Disc Swelling in Non-Syndromic Retinitis Pigmentosa: A Case Report.
    Am J Case Rep· 2026· PMID 41980014recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:791(Orphanet)
  2. OMIM OMIM:268000(OMIM)
  3. MONDO:0019200(MONDO)
  4. GARD:5694(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q847057(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Retinite pigmentosa
Compêndio · Raras BR

Retinite pigmentosa

ORPHA:791 · MONDO:0019200
Prevalência
1-5 / 10 000
Herança
Autosomal dominant, Autosomal recessive, Mitochondrial inheritance, X-linked recessive
CID-10
H35.5 · Distrofias hereditárias da retina
CID-11
Ensaios
40 ativos
Medicamentos
7 registrados
Início
Adolescent, Adult, Childhood
Prevalência
30.0 (Europe)
MedGen
UMLS
C0035334
Repurposing
1 candidato
luteinantioxidant
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥇 Ensaio rand.
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades